CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: ethylparaben
Accession: CHEBI:31575
browse the term
Definition: An ethyl ester resulting from the formal condensation of the carboxy group of 4-hydroxybenzoic acid with ethanol,
Synonyms: exact_synonym: ethyl 4-hydroxybenzoate
related_synonym: 4-hydroxybenzoic acid ethyl ester; E-214; E214; Ethyl parahydroxybenzoate; Formula=C9H10O3; InChI=1S/C9H10O3/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6,10H,2H2,1H3; InChIKey=NUVBSKCKDOMJSU-UHFFFAOYSA-N; SMILES=C(=O)(C1=CC=C(C=C1)O)OCC; ethyl p-hydroxybenzoate; ethyl paraben; p-Oxybenzoesaeureaethylester; p-hydroxybenzoic acid ethyl ester
alt_id: CHEBI:86616
xref: CAS:120-47-8; Drug_Central:4773; HMDB:HMDB0032573; KEGG:D01647; KNApSAcK:C00033837
xref_mesh: MESH:C012313
xref: PDBeChem:E4B; PMID:26901724; PMID:27106519; PMID:27377865; Reaxys:1101972; Wikipedia:Ethylparaben
G
Aadacl3
arylacetamide deacetylase-like 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of AADACL3 mRNA
CTD
PMID:37690743
NCBI chr 5:156,242,182...156,252,215
Ensembl chr 5:156,243,415...156,252,205
G
Aatk
apoptosis-associated tyrosine kinase
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of AATK mRNA
CTD
PMID:37690743
NCBI chr10:105,290,752...105,327,219
Ensembl chr10:105,291,585...105,327,112
G
Abca3
ATP binding cassette subfamily A member 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ABCA3 mRNA
CTD
PMID:37690743
NCBI chr10:13,382,439...13,439,748
Ensembl chr10:13,382,540...13,439,745
G
Abcc8
ATP binding cassette subfamily C member 8
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ABCC8 mRNA
CTD
PMID:37690743
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
G
Abcd2
ATP binding cassette subfamily D member 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ABCD2 mRNA
CTD
PMID:37690743
NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
G
Abcg4
ATP binding cassette subfamily G member 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ABCG4 mRNA
CTD
PMID:37690743
NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881
G
Abhd1
abhydrolase domain containing 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ABHD1 mRNA
CTD
PMID:37690743
NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
G
Acan
aggrecan
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ACAN mRNA
CTD
PMID:37690743
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
G
Acp3
acid phosphatase 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ACP3 mRNA
CTD
PMID:37690743
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
G
Acss1
acyl-CoA synthetase short-chain family member 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ACSS1 mRNA
CTD
PMID:37690743
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
G
Actl6b
actin-like 6B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ACTL6B mRNA
CTD
PMID:37690743
NCBI chr12:19,124,887...19,141,419
Ensembl chr12:19,124,916...19,141,376
G
Adam33
ADAM metallopeptidase domain 33
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ADAM33 mRNA
CTD
PMID:37690743
NCBI chr 3:118,262,395...118,283,456
Ensembl chr 3:118,271,029...118,283,461
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ADAMTS4 mRNA
CTD
PMID:37690743
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
G
Adamtsl1
ADAMTS-like 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ADAMTSL1 mRNA
CTD
PMID:37690743
NCBI chr 5:99,964,406...100,919,786
Ensembl chr 5:99,964,486...100,918,384
G
Adamtsl2
ADAMTS-like 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ADAMTSL2 mRNA
CTD
PMID:37690743
NCBI chr 3:10,397,774...10,434,557
Ensembl chr 3:10,404,626...10,434,554
G
Adap1
ArfGAP with dual PH domains 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ADAP1 mRNA
CTD
PMID:37690743
NCBI chr12:15,323,913...15,376,110
Ensembl chr12:15,324,209...15,380,831
G
Adcy10
adenylate cyclase 10
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ADCY10 mRNA
CTD
PMID:37690743
NCBI chr13:77,747,752...77,833,952
Ensembl chr13:77,768,468...77,833,951
G
Adcy8
adenylate cyclase 8
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ADCY8 mRNA
CTD
PMID:37690743
NCBI chr 7:96,417,310...96,665,911
Ensembl chr 7:96,417,324...96,665,911
G
Adgrb1
adhesion G protein-coupled receptor B1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ADGRB1 mRNA
CTD
PMID:37690743
NCBI chr 7:106,404,827...106,476,902
Ensembl chr 7:106,404,958...106,476,902
G
Adgrd2
adhesion G protein-coupled receptor D2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ADGRD2 mRNA
CTD
PMID:37690743
G
Adgrf1
adhesion G protein-coupled receptor F1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ADGRF1 mRNA
CTD
PMID:37690743
NCBI chr 9:17,661,258...17,696,359
Ensembl chr 9:17,660,930...17,711,704
G
Adgrg3
adhesion G protein-coupled receptor G3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ADGRG3 mRNA
CTD
PMID:37690743
NCBI chr19:9,972,425...10,001,118
Ensembl chr19:9,972,430...10,001,123
G
Adgrl4
adhesion G protein-coupled receptor L4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ADGRL4 mRNA
CTD
PMID:37690743
NCBI chr 2:240,354,909...240,457,231
Ensembl chr 2:240,354,941...240,457,225
G
Adipoq
adiponectin, C1Q and collagen domain containing
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ADIPOQ mRNA
CTD
PMID:22956630
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adra1b
adrenoceptor alpha 1B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ADRA1B mRNA
CTD
PMID:37690743
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
G
Afap1
actin filament associated protein 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of AFAP1 mRNA
CTD
PMID:37690743
NCBI chr14:74,743,322...74,856,300
Ensembl chr14:74,743,320...74,856,263
G
Agap2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of AGAP2 mRNA
CTD
PMID:37690743
NCBI chr 7:62,897,282...62,914,295
Ensembl chr 7:62,897,282...62,914,295
G
Ahr
aryl hydrocarbon receptor
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of AHR mRNA
CTD
PMID:37690743
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aif1
allograft inflammatory factor 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of AIF1 mRNA
CTD
PMID:37690743
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Aifm3
apoptosis inducing factor, mitochondria associated 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of AIFM3 mRNA
CTD
PMID:37690743
NCBI chr11:83,504,859...83,523,630
Ensembl chr11:83,504,861...83,521,248
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of AKR1C2 mRNA
CTD
PMID:37690743
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of AKR1C3 mRNA
CTD
PMID:37690743
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ALDH1A2 mRNA
CTD
PMID:37690743
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Alox15
arachidonate 15-lipoxygenase
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ALOX15 mRNA
CTD
PMID:37690743
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
G
Als2cl
ALS2 C-terminal like
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ALS2CL mRNA
CTD
PMID:37690743
NCBI chr 8:110,863,753...110,884,434
Ensembl chr 8:110,864,975...110,884,419
G
Ambn
ameloblastin
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of AMBN mRNA
CTD
PMID:37690743
NCBI chr14:19,601,761...19,614,382
Ensembl chr14:19,601,702...19,614,393
G
Angpt4
angiopoietin 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ANGPT4 mRNA
CTD
PMID:37690743
NCBI chr 3:140,420,389...140,454,213
Ensembl chr 3:140,420,389...140,453,583
G
Ankdd1b
ankyrin repeat and death domain containing 1B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ANKDD1B mRNA
CTD
PMID:37690743
NCBI chr 2:27,750,301...27,814,291
Ensembl chr 2:27,750,987...27,813,734
G
Ankrd24
ankyrin repeat domain 24
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ANKRD24 mRNA
CTD
PMID:37690743
NCBI chr 7:8,061,634...8,081,142
Ensembl chr 7:8,061,953...8,081,142
G
Ankrd53
ankyrin repeat domain 53
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ANKRD53 mRNA
CTD
PMID:37690743
NCBI chr 4:116,245,561...116,253,018
Ensembl chr 4:116,246,955...116,253,017
G
Apbb1ip
amyloid beta precursor protein binding family B member 1 interacting protein
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of APBB1IP mRNA
CTD
PMID:37690743
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
G
Apc2
APC regulator of WNT signaling pathway 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of APC2 mRNA
CTD
PMID:37690743
NCBI chr 7:9,392,336...9,414,364
Ensembl chr 7:9,392,336...9,414,310
G
Apol2
apolipoprotein L2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of APOL2 mRNA
CTD
PMID:37690743
NCBI chr 7:109,331,367...109,338,632
Ensembl chr 7:109,331,392...109,338,558
G
Ar
androgen receptor
multiple interactions
ISO
ethyl-p-hydroxybenzoate inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein]
CTD
PMID:29162470
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arhgap10
Rho GTPase activating protein 10
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ARHGAP10 mRNA
CTD
PMID:37690743
NCBI chr19:30,448,572...30,710,315
Ensembl chr19:30,448,637...30,710,313
G
Arhgap40
Rho GTPase activating protein 40
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ARHGAP40 mRNA
CTD
PMID:37690743
NCBI chr 3:147,165,781...147,206,552
Ensembl chr 3:147,165,729...147,207,203
G
Arid3c
AT-rich interaction domain 3C
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ARID3C mRNA
CTD
PMID:37690743
NCBI chr 5:56,889,649...56,896,959
Ensembl chr 5:56,890,042...56,895,888
G
Armc12
armadillo repeat containing 12
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ARMC12 mRNA
CTD
PMID:37690743
NCBI chr20:6,587,859...6,598,355
Ensembl chr20:6,587,859...6,598,352
G
Arsl
arylsulfatase L
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ARSL mRNA
CTD
PMID:37690743
NCBI chr 2:119,038,803...119,047,579
Ensembl chr 2:119,038,921...119,046,846
G
Atp1a3
ATPase Na+/K+ transporting subunit alpha 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ATP1A3 mRNA
CTD
PMID:37690743
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
G
Atp2b2
ATPase plasma membrane Ca2+ transporting 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ATP2B2 mRNA
CTD
PMID:37690743
NCBI chr 4:146,894,602...147,208,060
Ensembl chr 4:146,896,332...147,140,665
G
Atp4a
ATPase H+/K+ transporting subunit alpha
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ATP4A mRNA
CTD
PMID:37690743
NCBI chr 1:85,961,607...85,974,972
Ensembl chr 1:85,961,708...85,974,844
G
Begain
brain-enriched guanylate kinase-associated
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of BEGAIN mRNA
CTD
PMID:37690743
NCBI chr 6:127,943,651...127,979,876
Ensembl chr 6:127,943,651...127,979,841
G
Bfsp1
beaded filament structural protein 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of BFSP1 mRNA
CTD
PMID:37690743
NCBI chr 3:131,195,087...131,252,668
Ensembl chr 3:131,195,087...131,229,337
G
Bglap
bone gamma-carboxyglutamate protein
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of BGLAP mRNA
CTD
PMID:37690743
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Bhmt2
betaine-homocysteine S-methyltransferase 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of BHMT2 mRNA
CTD
PMID:37690743
NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475
G
Bicdl2
BICD family like cargo adaptor 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of BICDL2 mRNA
CTD
PMID:37690743
NCBI chr10:12,691,610...12,700,049
Ensembl chr10:12,691,610...12,700,049
G
Bmp3
bone morphogenetic protein 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of BMP3 mRNA
CTD
PMID:37690743
NCBI chr14:10,712,489...10,737,153
Ensembl chr14:10,712,489...10,737,153
G
Bmp8b
bone morphogenetic protein 8b
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of BMP8B mRNA
CTD
PMID:37690743
NCBI chr 5:135,386,058...135,411,337
Ensembl chr 5:135,386,311...135,405,197
G
Bola2
bolA family member 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of BOLA2 mRNA
CTD
PMID:37690743
NCBI chr 1:181,291,967...181,292,833
Ensembl chr 1:181,291,398...181,292,676
G
Bst1
bone marrow stromal cell antigen 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of BST1 mRNA
CTD
PMID:37690743
NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180
G
C13h1orf116
similar to human chromosome 1 open reading frame 116
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of C1ORF116 mRNA
CTD
PMID:37690743
NCBI chr13:42,187,442...42,201,432
Ensembl chr13:42,188,609...42,201,426
G
C1h19orf81
simlar to human chromosome 19 open reading frame 81
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of C19ORF81 mRNA
CTD
PMID:37690743
NCBI chr 1:94,857,301...94,871,323
Ensembl chr 1:94,857,115...94,871,813
G
C1h19orf85
similar to human chromosome 19 open reading frame 85
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of C19ORF85 mRNA
CTD
PMID:37690743
NCBI chr 1:68,929,184...68,937,113
Ensembl chr 1:68,929,333...68,936,922
G
C1ql1
complement C1q like 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of C1QL1 mRNA
CTD
PMID:37690743
NCBI chr10:87,902,125...87,909,556
Ensembl chr10:87,902,137...87,909,310
G
C1ql4
complement C1q like 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of C1QL4 mRNA
CTD
PMID:37690743
NCBI chr 7:130,243,606...130,246,678
Ensembl chr 7:130,243,606...130,246,678
G
C20h10orf105
similar to human chromosome 10 open reading frame 105
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of C10ORF105 mRNA
CTD
PMID:37690743
NCBI chr20:28,333,094...28,339,341
Ensembl chr20:28,336,101...28,336,487
G
C20h6orf15
similar to human chromosome 6 open reading frame 15
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of C6ORF15 mRNA
CTD
PMID:37690743
NCBI chr20:3,172,330...3,173,886
Ensembl chr20:3,172,330...3,173,886
G
C2cd4c
C2 calcium-dependent domain containing 4C
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of C2CD4C mRNA
CTD
PMID:37690743
NCBI chr 7:10,090,651...10,095,426
Ensembl chr 7:10,092,138...10,095,421
G
C5h1orf127
similar to human chromosome 1 open reading frame 127
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of C1ORF127 mRNA
CTD
PMID:37690743
NCBI chr 5:159,075,217...159,110,642
Ensembl chr 5:159,075,343...159,105,369
G
C8h11orf52
similar to human chromosome 11 open reading frame 52
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of C11ORF52 mRNA
CTD
PMID:37690743
NCBI chr 8:51,081,342...51,088,333
Ensembl chr 8:51,081,342...51,094,533
G
Cab39l
calcium binding protein 39-like
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CAB39L mRNA
CTD
PMID:37690743
NCBI chr15:33,606,588...33,710,518
Ensembl chr15:33,606,694...33,743,545
G
Cabp1
calcium binding protein 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CABP1 mRNA
CTD
PMID:37690743
NCBI chr12:41,385,234...41,448,930
Ensembl chr12:41,378,897...41,448,927
G
Cacna1b
calcium voltage-gated channel subunit alpha1 B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CACNA1B mRNA
CTD
PMID:37690743
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
G
Cacna1e
calcium voltage-gated channel subunit alpha1 E
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CACNA1E mRNA
CTD
PMID:37690743
NCBI chr13:66,574,659...67,063,443
Ensembl chr13:66,581,920...66,894,450
G
Cacna1f
calcium voltage-gated channel subunit alpha1 F
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CACNA1F mRNA
CTD
PMID:37690743
NCBI chr X:14,868,096...14,896,413
Ensembl chr X:14,868,024...14,896,413
G
Cacng4
calcium voltage-gated channel auxiliary subunit gamma 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CACNG4 mRNA
CTD
PMID:37690743
NCBI chr10:92,683,778...92,745,842
Ensembl chr10:92,683,761...92,746,126
G
Cacng7
calcium voltage-gated channel auxiliary subunit gamma 7
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CACNG7 mRNA
CTD
PMID:37690743
NCBI chr 1:65,800,059...65,831,246
Ensembl chr 1:65,800,355...65,831,006
G
Calb2
calbindin 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CALB2 mRNA
CTD
PMID:37690743
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
G
Calhm5
calcium homeostasis modulator family member 5
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CALHM5 mRNA
CTD
PMID:37690743
NCBI chr20:26,066,270...26,072,348
Ensembl chr20:26,066,242...26,072,272
G
Caly
calcyon neuron-specific vesicular protein
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CALY mRNA
CTD
PMID:37690743
NCBI chr 1:194,862,671...194,873,861
Ensembl chr 1:194,862,672...194,873,551
G
Car8
carbonic anhydrase 8
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CA8 mRNA
CTD
PMID:37690743
NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374
G
Card11
caspase recruitment domain family, member 11
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CARD11 mRNA
CTD
PMID:37690743
NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112
G
Carmil3
capping protein regulator and myosin 1 linker 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CARMIL3 mRNA
CTD
PMID:37690743
NCBI chr15:28,978,440...28,995,865
Ensembl chr15:28,979,007...28,996,225
G
Catsper4
cation channel, sperm associated 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CATSPER4 mRNA
CTD
PMID:37690743
NCBI chr 5:146,427,682...146,447,346
Ensembl chr 5:146,427,683...146,446,942
G
Ccdc120
coiled-coil domain containing 120
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CCDC120 mRNA
CTD
PMID:37690743
NCBI chr X:14,753,594...14,772,745
Ensembl chr X:14,753,696...14,772,743
G
Ccdc141
coiled-coil domain containing 141
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CCDC141 mRNA
CTD
PMID:37690743
NCBI chr 3:61,948,614...62,109,968
Ensembl chr 3:61,948,646...62,110,079
G
Ccdc171
coiled-coil domain containing 171
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CCDC171 mRNA
CTD
PMID:37690743
NCBI chr 5:97,919,965...98,403,853
Ensembl chr 5:97,920,002...98,282,833
G
Ccdc194
coiled-coil domain containing 194
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CCDC194 mRNA
CTD
PMID:37690743
NCBI chr16:18,205,099...18,209,310
Ensembl chr16:18,205,095...18,209,283
G
Ccdc39
coiled-coil domain 39 molecular ruler complex subunit
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CCDC39 mRNA
CTD
PMID:37690743
NCBI chr 2:116,665,651...116,703,354
Ensembl chr 2:116,665,261...116,703,350
G
Ccdc63
coiled-coil domain containing 63
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CCDC63 mRNA
CTD
PMID:37690743
NCBI chr12:34,424,388...34,453,080
Ensembl chr12:34,424,344...34,453,085
G
Ccdc68
coiled-coil domain containing 68
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CCDC68 mRNA
CTD
PMID:37690743
NCBI chr18:63,541,828...63,584,122
Ensembl chr18:63,541,896...63,584,119
G
Ccdc96
coiled-coil domain containing 96
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CFAP184 mRNA
CTD
PMID:37690743
NCBI chr14:74,276,568...74,279,072
Ensembl chr14:74,276,960...74,278,888
G
Ccr7
C-C motif chemokine receptor 7
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CCR7 mRNA
CTD
PMID:37690743
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
G
Ccser1
coiled-coil serine-rich protein 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CCSER1 mRNA
CTD
PMID:37690743
NCBI chr 4:90,153,873...91,391,441
Ensembl chr 4:90,292,780...91,388,786
G
Cd109
CD109 molecule
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CD109 mRNA
CTD
PMID:37690743
NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194
G
Cd177
CD177 molecule
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CD177 mRNA
CTD
PMID:37690743
NCBI chr 1:80,340,034...80,360,599
Ensembl chr 1:80,340,034...80,360,621
G
Cdc42bpg
CDC42 binding protein kinase gamma
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CDC42BPG mRNA
CTD
PMID:37690743
NCBI chr 1:203,608,339...203,628,502
Ensembl chr 1:203,608,574...203,628,502
G
Cdh17
cadherin 17
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CDH17 mRNA
CTD
PMID:37690743
NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884
G
Cdh20
cadherin 20
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CDH20 mRNA
CTD
PMID:37690743
NCBI chr13:20,737,640...21,069,746
Ensembl chr13:20,738,081...21,068,676
G
Cdhr1
cadherin-related family member 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CDHR1 mRNA
CTD
PMID:37690743
NCBI chr16:12,843,436...12,863,321
Ensembl chr16:12,843,437...12,863,396
G
Cdkl1
cyclin dependent kinase like 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CDKL1 mRNA
CTD
PMID:37690743
NCBI chr 6:88,224,154...88,273,434
Ensembl chr 6:88,224,143...88,270,276
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CDKN2A mRNA
CTD
PMID:37690743
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cdkn2d
cyclin dependent kinase inhibitor 2D
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CDKN2D mRNA
CTD
PMID:37690743
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
G
Cebpa
CCAAT/enhancer binding protein alpha
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CEBPA mRNA
CTD
PMID:22956630
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cend1
cell cycle exit and neuronal differentiation 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CEND1 mRNA
CTD
PMID:37690743
NCBI chr 1:196,525,153...196,528,152
Ensembl chr 1:196,523,920...196,528,302
G
Cfap107
cilia and flagella associated protein 107
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CFAP107 mRNA
CTD
PMID:37690743
NCBI chr 5:156,212,385...156,231,481
Ensembl chr 5:156,212,385...156,231,481
G
Cga
glycoprotein hormones, alpha polypeptide
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CGA mRNA
CTD
PMID:37690743
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
G
Chd5
chromodomain helicase DNA binding protein 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CHD5 mRNA
CTD
PMID:37690743
NCBI chr 5:162,848,273...162,898,997
Ensembl chr 5:162,848,394...162,896,291
G
Chrna4
cholinergic receptor nicotinic alpha 4 subunit
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CHRNA4 mRNA
CTD
PMID:37690743
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
G
Cibar2
CBY1 interacting BAR domain containing 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CIBAR2 mRNA
CTD
PMID:37690743
NCBI chr19:48,217,617...48,229,418
Ensembl chr19:48,215,486...48,229,404
G
Cimap3
ciliary microtubule associated protein 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CIMAP3 mRNA
CTD
PMID:37690743
NCBI chr 2:193,475,785...193,493,092
Ensembl chr 2:193,475,782...193,493,139
G
Cldn2
claudin 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CLDN2 mRNA
CTD
PMID:37690743
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
G
Cldn9
claudin 9
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CLDN9 mRNA
CTD
PMID:37690743
NCBI chr10:12,714,137...12,715,568
G
Clec18a
C-type lectin domain family 18, member A
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CLEC18A mRNA
CTD
PMID:37690743
NCBI chr19:39,038,498...39,053,425
Ensembl chr19:39,038,273...39,056,017
G
Clpsl2
colipase-like 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CLPSL2 mRNA
CTD
PMID:37690743
NCBI chr20:6,608,128...6,610,951
Ensembl chr20:6,608,128...6,610,951
G
Clvs2
clavesin 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CLVS2 mRNA
CTD
PMID:37690743
NCBI chr 1:23,735,660...23,842,685
Ensembl chr 1:23,735,272...23,842,692
G
Cntfr
ciliary neurotrophic factor receptor
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CNTFR mRNA
CTD
PMID:37690743
NCBI chr 5:56,823,448...56,861,049
Ensembl chr 5:56,823,965...56,841,392
G
Cntnap3
contactin associated protein family member 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CNTNAP3 mRNA
CTD
PMID:37690743
NCBI chr17:267,379...455,478
Ensembl chr17:267,508...454,102
G
Coro6
coronin 6
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CORO6 mRNA
CTD
PMID:37690743
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
G
Cox6b2
cytochrome c oxidase subunit 6B2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of COX6B2 mRNA
CTD
PMID:37690743
NCBI chr 1:69,094,009...69,095,312
G
Cpne7
copine 7
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CPNE7 mRNA
CTD
PMID:37690743
NCBI chr19:51,164,316...51,182,676
Ensembl chr19:51,166,034...51,182,677
G
Cpne9
copine family member 9
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CPNE9 mRNA
CTD
PMID:37690743
NCBI chr 4:146,429,961...146,454,335
Ensembl chr 4:146,430,792...146,454,333
G
Crb1
crumbs cell polarity complex component 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CRB1 mRNA
CTD
PMID:37690743
NCBI chr13:50,801,484...50,989,261
Ensembl chr13:50,800,959...50,989,261
G
Crb2
crumbs cell polarity complex component 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CRB2 mRNA
CTD
PMID:37690743
NCBI chr 3:21,542,138...21,564,876
Ensembl chr 3:21,542,221...21,563,294
G
Creb3l3
cAMP responsive element binding protein 3-like 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CREB3L3 mRNA
CTD
PMID:37690743
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
G
Crip2
cysteine-rich protein 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CRIP2 mRNA
CTD
PMID:37690743
NCBI chr 6:132,221,120...132,226,066
Ensembl chr 6:132,221,082...132,226,065
G
Crppa
CDP-L-ribitol pyrophosphorylase A
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CRPPA mRNA
CTD
PMID:37690743
NCBI chr 6:53,120,264...53,397,030
Ensembl chr 6:53,121,438...53,397,028
G
Crybb1
crystallin, beta B1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CRYBB1 mRNA
CTD
PMID:37690743
NCBI chr12:44,369,734...44,383,344
Ensembl chr12:44,369,735...44,383,344
G
Crygd
crystallin, gamma D
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CRYGD mRNA
CTD
PMID:37690743
NCBI chr 9:66,442,057...66,443,668
Ensembl chr 9:66,442,054...66,444,067
G
Crym
crystallin, mu
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CRYM mRNA
CTD
PMID:37690743
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
G
Csf3r
colony stimulating factor 3 receptor
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CSF3R mRNA
CTD
PMID:37690743
NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881
G
Cygb
cytoglobin
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CYGB mRNA
CTD
PMID:37690743
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CYP19A1 mRNA
CTD
PMID:37690743
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity
EXP
ethyl-p-hydroxybenzoate results in decreased activity of CYP1A1 protein
CTD
PMID:27432241
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases activity
EXP
ethyl-p-hydroxybenzoate results in decreased activity of CYP1A2 protein
CTD
PMID:27432241
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CYP27A1 mRNA
CTD
PMID:37690743
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
decreases activity
EXP
ethyl-p-hydroxybenzoate results in decreased activity of CYP2B1 protein
CTD
PMID:27432241
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases activity
EXP
ethyl-p-hydroxybenzoate results in decreased activity of CYP2C11 protein
CTD
PMID:27432241
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity
EXP
ethyl-p-hydroxybenzoate results in decreased activity of CYP2E1 protein
CTD
PMID:27432241
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
decreases activity
EXP
ethyl-p-hydroxybenzoate results in decreased activity of CYP3A62 protein
CTD
PMID:27432241
NCBI chr12:16,397,998...16,433,833
Ensembl chr12:16,397,998...16,433,833
G
Cyp4f39
cytochrome P450, family 4, subfamily f, polypeptide 39
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of CYP4F22 mRNA
CTD
PMID:37690743
NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of CYP7B1 mRNA
CTD
PMID:37690743
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
G
Dclk2
doublecortin-like kinase 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DCLK2 mRNA
CTD
PMID:37690743
NCBI chr 2:172,202,733...172,338,411
Ensembl chr 2:172,208,706...172,338,250
G
Dclk3
doublecortin-like kinase 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DCLK3 mRNA
CTD
PMID:37690743
NCBI chr 8:111,401,544...111,453,999
Ensembl chr 8:111,401,358...111,453,999
G
Def6
DEF6 guanine nucleotide exchange factor
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DEF6 mRNA
CTD
PMID:37690743
NCBI chr20:6,268,579...6,290,030
Ensembl chr20:6,268,601...6,289,961
G
Dgki
diacylglycerol kinase, iota
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DGKI mRNA
CTD
PMID:37690743
NCBI chr 4:65,410,878...65,872,733
Ensembl chr 4:65,420,108...65,872,733
G
Dkk2
dickkopf WNT signaling pathway inhibitor 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DKK2 mRNA
CTD
PMID:37690743
NCBI chr 2:220,568,338...220,660,225
Ensembl chr 2:220,568,338...220,660,225
G
Dkk4
dickkopf WNT signaling pathway inhibitor 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DKK4 mRNA
CTD
PMID:37690743
NCBI chr16:69,403,215...69,406,580
Ensembl chr16:69,402,989...69,406,580
G
Dkkl1
dickkopf like acrosomal protein 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DKKL1 mRNA
CTD
PMID:37690743
NCBI chr 1:95,694,010...95,699,259
Ensembl chr 1:95,694,010...95,699,259
G
Dlec1
DLEC1 cilia and flagella associated protein
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DLEC1 mRNA
CTD
PMID:37690743
NCBI chr 8:118,826,429...118,873,183
Ensembl chr 8:118,826,466...118,873,655
G
Dleu7
deleted in lymphocytic leukemia, 7
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DLEU7 mRNA
CTD
PMID:37690743
NCBI chr15:36,479,533...36,495,730
Ensembl chr15:36,479,534...36,495,697
G
Dmbx1
diencephalon/mesencephalon homeobox 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DMBX1 mRNA
CTD
PMID:37690743
NCBI chr 5:129,394,221...129,403,040
Ensembl chr 5:129,394,221...129,403,040
G
Dmrta2
DMRT-like family A2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DMRTA2 mRNA
CTD
PMID:37690743
NCBI chr 5:124,805,883...124,811,694
Ensembl chr 5:124,805,883...124,811,630
G
Dnai3
dynein axonemal intermediate chain 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DNAI3 mRNA
CTD
PMID:37690743
NCBI chr 2:234,947,910...235,006,173
Ensembl chr 2:234,929,677...235,006,173
G
Dnm1
dynamin 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DNM1 mRNA
CTD
PMID:37690743
NCBI chr 3:15,604,782...15,648,654
Ensembl chr 3:15,604,784...15,648,538
G
Dnm3
dynamin 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DNM3 mRNA
CTD
PMID:37690743
NCBI chr13:74,359,043...74,838,135
Ensembl chr13:74,359,213...74,838,108
G
Dnmt3l
DNA methyltransferase 3 like
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DNMT3L mRNA
CTD
PMID:37690743
NCBI chr20:10,614,933...10,629,337
Ensembl chr20:10,614,934...10,629,516
G
Doc2a
double C2 domain alpha
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DOC2A mRNA
CTD
PMID:37690743
NCBI chr 1:181,457,415...181,462,528
Ensembl chr 1:181,458,390...181,462,030
G
Dok3
docking protein 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DOK3 mRNA
CTD
PMID:37690743
NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188
G
Dppa3
developmental pluripotency-associated 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DPPA3 mRNA
CTD
PMID:37690743
NCBI chr 4:155,851,461...155,854,845
Ensembl chr 4:155,815,296...155,854,861 Ensembl chr 5:155,815,296...155,854,861
G
Dsc1
desmocollin 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DSC1 mRNA
CTD
PMID:37690743
NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494
G
Dsg3
desmoglein 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DSG3 mRNA
CTD
PMID:37690743
NCBI chr18:11,799,355...11,830,988
Ensembl chr18:11,798,900...11,830,818
G
Dtx1
deltex E3 ubiquitin ligase 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DTX1 mRNA
CTD
PMID:37690743
NCBI chr12:35,849,647...35,880,835
Ensembl chr12:35,849,617...35,880,838
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DUSP10 mRNA
CTD
PMID:37690743
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
G
Dusp9
dual specificity phosphatase 9
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DUSP9 mRNA
CTD
PMID:37690743
NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821
G
Dydc2
DPY30 domain containing 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DYDC2 mRNA
CTD
PMID:37690743
NCBI chr16:16,928,172...16,941,950
Ensembl chr16:16,928,194...16,936,164
G
Dyrk3
dual specificity tyrosine phosphorylation regulated kinase 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DYRK3 mRNA
CTD
PMID:37690743
NCBI chr13:42,594,120...42,604,898
Ensembl chr13:42,594,121...42,604,778
G
Dysf
dysferlin
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of DYSF mRNA
CTD
PMID:37690743
NCBI chr 4:116,490,877...116,690,709
Ensembl chr 4:116,490,616...116,690,709
G
Dzip1l
DAZ interacting zinc finger protein 1-like
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of DZIP1L mRNA
CTD
PMID:37690743
NCBI chr 8:100,188,414...100,229,077
Ensembl chr 8:100,194,999...100,228,988
G
Ebi3
Epstein-Barr virus induced 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of EBI3 mRNA
CTD
PMID:37690743
NCBI chr 9:774,252...787,544
Ensembl chr 9:783,617...787,544
G
Egflam
EGF-like, fibronectin type III and laminin G domains
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of EGFLAM mRNA
CTD
PMID:37690743
NCBI chr 2:56,301,945...56,476,665
Ensembl chr 2:56,302,566...56,476,298
G
Eln
elastin
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ELN mRNA
CTD
PMID:37690743
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
G
Emilin3
elastin microfibril interfacer 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of EMILIN3 mRNA
CTD
PMID:37690743
NCBI chr 3:149,558,785...149,564,785
Ensembl chr 3:149,558,970...149,564,785
G
Epha10
EPH receptor A10
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of EPHA10 mRNA
CTD
PMID:37690743
NCBI chr 5:137,139,588...137,175,637
Ensembl chr 5:137,140,735...137,174,157
G
Epha8
Eph receptor A8
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of EPHA8 mRNA
CTD
PMID:37690743
NCBI chr 5:149,166,107...149,193,515
Ensembl chr 5:149,166,697...149,193,399
G
Ephx1
epoxide hydrolase 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of EPHX1 mRNA
CTD
PMID:37690743
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Erfe
erythroferrone
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ERFE mRNA
CTD
PMID:37690743
NCBI chr 9:91,956,971...91,964,846
Ensembl chr 9:91,956,977...91,964,846
G
Ervfrd-1
endogenous retrovirus group FRD member 1, envelope
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ERVFRD-1 mRNA
CTD
PMID:37690743
NCBI chr12:22,151,211...22,158,264
Ensembl chr12:22,151,211...22,158,264
G
Ervv-2
endogenous retrovirus group V member 2, envelope
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ERVV-2 mRNA
CTD
PMID:37690743
NCBI chr 3:119,129,119...119,135,004
Ensembl chr 3:119,131,071...119,131,670
G
Esam
endothelial cell adhesion molecule
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ESAM mRNA
CTD
PMID:37690743
NCBI chr 8:37,238,228...37,249,217
Ensembl chr 8:37,238,287...37,249,215
G
Esr1
estrogen receptor 1
multiple interactions affects binding increases activity
ISO EXP
ethyl-p-hydroxybenzoate binds to and results in increased activity of ESR1 protein ethyl-p-hydroxybenzoate binds to ESR1 protein ethyl-p-hydroxybenzoate results in increased activity of ESR1 protein
CTD
PMID:11193391 PMID:20132880 PMID:23567241 PMID:25012808 PMID:29162470
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
affects binding multiple interactions
ISO EXP
ethyl-p-hydroxybenzoate binds to ESR2 protein ethyl-p-hydroxybenzoate binds to and results in increased activity of ESR2 protein
CTD
PMID:11193391 PMID:20132880 PMID:23567241
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esrp2
epithelial splicing regulatory protein 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ESRP2 mRNA
CTD
PMID:37690743
NCBI chr19:34,034,559...34,041,726
Ensembl chr19:34,034,559...34,041,726
G
Esrrb
estrogen-related receptor beta
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ESRRB mRNA
CTD
PMID:37690743
NCBI chr 6:106,007,701...106,163,136
Ensembl chr 6:106,008,095...106,160,791
G
Esrrg
estrogen-related receptor gamma
multiple interactions
ISO
ethyl-p-hydroxybenzoate inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]
CTD
PMID:23583298
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
G
Eva1b
eva-1 homolog B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of EVA1B mRNA
CTD
PMID:37690743
NCBI chr 5:138,427,088...138,429,602
Ensembl chr 5:138,427,151...138,432,433
G
F10
coagulation factor X
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of F10 mRNA
CTD
PMID:37690743
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
G
F7
coagulation factor VII
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of F7 mRNA
CTD
PMID:37690743
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Fabp3
fatty acid binding protein 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FABP3 mRNA
CTD
PMID:37690743
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
G
Fabp4
fatty acid binding protein 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FABP4 mRNA
CTD
PMID:22956630
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Faim2
Fas apoptotic inhibitory molecule 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FAIM2 mRNA
CTD
PMID:37690743
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
G
Fam131c
family with sequence similarity 131, member C
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FAM131C mRNA
CTD
PMID:37690743
NCBI chr 5:153,674,459...153,690,791
Ensembl chr 5:153,671,772...153,690,800
G
Fam163b
family with sequence similarity 163, member B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FAM163B mRNA
CTD
PMID:37690743
NCBI chr 3:10,437,383...10,466,458
Ensembl chr 3:10,437,383...10,466,458
G
Fam219a
family with sequence similarity 219, member A
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FAM219A mRNA
CTD
PMID:37690743
NCBI chr 5:56,679,272...56,729,959
Ensembl chr 5:56,680,613...56,729,924
G
Fam228a
family with sequence similarity 228, member A
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FAM228A mRNA
CTD
PMID:37690743
NCBI chr 6:27,727,982...27,750,140
Ensembl chr 6:27,727,984...27,750,061
G
Fbxo43
F-box protein 43
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FBXO43 mRNA
CTD
PMID:37690743
NCBI chr 7:67,333,161...67,346,751
Ensembl chr 7:67,333,162...67,346,751
G
Fbxw12
F-box and WD repeat domain containing 12
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FBXW12 mRNA
CTD
PMID:37690743
NCBI chr 8:109,782,315...109,802,086
Ensembl chr 8:109,786,815...109,801,813
G
Fcgbp
Fc gamma binding protein
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FCGBP mRNA
CTD
PMID:37690743
NCBI chr 1:83,374,979...83,413,082
Ensembl chr 1:83,372,127...83,413,083
G
Fer1l5
fer-1-like family member 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FER1L5 mRNA
CTD
PMID:37690743
NCBI chr 9:38,605,835...38,661,869
Ensembl chr 9:38,607,843...38,660,425
G
Fezf1
Fez family zinc finger 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FEZF1 mRNA
CTD
PMID:37690743
NCBI chr 4:51,762,751...51,766,078
Ensembl chr 4:51,762,751...51,766,078
G
Fezf2
Fez family zinc finger 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FEZF2 mRNA
CTD
PMID:37690743
NCBI chr15:12,768,614...12,777,554
Ensembl chr15:12,773,762...12,777,554
G
Fgd5
FYVE, RhoGEF and PH domain containing 5
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FGD5 mRNA
CTD
PMID:37690743
NCBI chr 4:124,497,061...124,594,564
Ensembl chr 4:124,497,068...124,594,563
G
Fgf1
fibroblast growth factor 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FGF1 mRNA
CTD
PMID:37690743
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Fgf10
fibroblast growth factor 10
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FGF10 mRNA
CTD
PMID:37690743
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
G
Fgf23
fibroblast growth factor 23
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FGF23 mRNA
CTD
PMID:37690743
NCBI chr 4:159,914,267...159,923,821
Ensembl chr 4:159,914,272...159,923,821
G
Fgf4
fibroblast growth factor 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FGF4 mRNA
CTD
PMID:37690743
NCBI chr 1:200,023,937...200,027,793
Ensembl chr 1:200,024,056...200,025,466
G
Fgf9
fibroblast growth factor 9
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FGF9 mRNA
CTD
PMID:37690743
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
G
Fgfbp1
fibroblast growth factor binding protein 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FGFBP1 mRNA
CTD
PMID:37690743
NCBI chr14:67,103,686...67,107,492
Ensembl chr14:67,104,545...67,107,496
G
Fggy
FGGY carbohydrate kinase domain containing
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FGGY mRNA
CTD
PMID:37690743
NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017
G
Fibcd1
fibrinogen C domain containing 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FIBCD1 mRNA
CTD
PMID:37690743
NCBI chr 3:15,092,682...15,126,371
Ensembl chr 3:15,092,681...15,126,399
G
Fibin
fin bud initiation factor homolog
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FIBIN mRNA
CTD
PMID:37690743
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
G
Flnb
filamin B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FLNB mRNA
CTD
PMID:37690743
NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006
G
Flnc
filamin C
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FLNC mRNA
CTD
PMID:37690743
NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844
G
Flt3
Fms related receptor tyrosine kinase 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FLT3 mRNA
CTD
PMID:37690743
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Fmo4
flavin containing dimethylaniline monoxygenase 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FMO4 mRNA
CTD
PMID:37690743
NCBI chr13:75,154,683...75,172,874
Ensembl chr13:75,154,684...75,172,874
G
Fmod
fibromodulin
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FMOD mRNA
CTD
PMID:37690743
NCBI chr13:45,493,517...45,504,134
Ensembl chr13:45,493,517...45,504,133
G
Fndc10
fibronectin type III domain containing 10
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FNDC10 mRNA
CTD
PMID:37690743
NCBI chr 5:166,299,587...166,311,477
Ensembl chr 5:166,300,122...166,310,326
G
Foxd3
forkhead box D3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FOXD3 mRNA
CTD
PMID:37690743
NCBI chr 5:114,335,084...114,337,450
Ensembl chr 5:114,335,408...114,336,817
G
Foxi2
forkhead box I2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FOXI2 mRNA
CTD
PMID:37690743
NCBI chr 1:190,222,857...190,226,657
Ensembl chr 1:190,222,703...190,226,433
G
Foxi3
forkhead box I3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FOXI3 mRNA
CTD
PMID:37690743
NCBI chr 4:102,933,487...102,937,655
Ensembl chr 4:102,933,409...102,937,655
G
Foxn4
forkhead box N4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FOXN4 mRNA
CTD
PMID:37690743
NCBI chr12:42,336,706...42,359,932
Ensembl chr12:42,340,323...42,359,921
G
Frmd1
FERM domain containing 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FRMD1 mRNA
CTD
PMID:37690743
NCBI chr 1:55,079,285...55,090,230
G
Frmd6
FERM domain containing 6
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FRMD6 mRNA
CTD
PMID:37690743
NCBI chr 6:89,345,983...89,419,579
Ensembl chr 6:89,346,035...89,419,579
G
Frmpd3
FERM and PDZ domain containing 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FRMPD3 mRNA
CTD
PMID:37690743
NCBI chr X:103,964,168...104,113,864
Ensembl chr X:104,043,194...104,111,968
G
Frrs1
ferric-chelate reductase 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of FRRS1 mRNA
CTD
PMID:37690743
NCBI chr 2:204,820,898...204,881,487
Ensembl chr 2:204,823,025...204,895,540
G
Fxyd1
FXYD domain-containing ion transport regulator 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FXYD1 mRNA
CTD
PMID:37690743
NCBI chr 1:86,287,163...86,291,478
Ensembl chr 1:86,287,165...86,291,278
G
Fxyd2
FXYD domain-containing ion transport regulator 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FXYD2 mRNA
CTD
PMID:37690743
NCBI chr 8:45,712,901...45,720,032
Ensembl chr 8:45,712,903...45,720,203
G
Fxyd7
FXYD domain-containing ion transport regulator 7
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of FXYD7 mRNA
CTD
PMID:37690743
NCBI chr 1:86,277,678...86,286,954
Ensembl chr 1:86,277,678...86,286,954
G
Gabra3
gamma-aminobutyric acid type A receptor subunit alpha 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GABRA3 mRNA
CTD
PMID:37690743
NCBI chr X:150,244,745...150,501,566
Ensembl chr X:150,261,607...150,501,559
G
Gad2
glutamate decarboxylase 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GAD2 mRNA
CTD
PMID:37690743
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GADD45A mRNA
CTD
PMID:37690743
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Galr1
galanin receptor 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GALR1 mRNA
CTD
PMID:37690743
NCBI chr18:75,772,021...75,787,577
Ensembl chr18:75,772,023...75,787,577
G
Garin5b
golgi associated RAB2 interactor family member 5B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GARIN5B mRNA
CTD
PMID:37690743
NCBI chr 1:69,076,839...69,093,877
Ensembl chr 1:69,077,207...69,095,316
G
Garnl3
GTPase activating Rap/RanGAP domain-like 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GARNL3 mRNA
CTD
PMID:37690743
NCBI chr 3:16,288,718...16,432,308
Ensembl chr 3:16,288,719...16,430,837
G
Gas2l2
growth arrest-specific 2 like 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GAS2L2 mRNA
CTD
PMID:37690743
NCBI chr10:68,222,475...68,229,877
Ensembl chr10:68,222,475...68,229,881
G
Gbe1
1,4-alpha-glucan branching enzyme 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GBE1 mRNA
CTD
PMID:37690743
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
G
Gbp4
guanylate binding protein 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GBP4 mRNA
CTD
PMID:37690743
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
G
Gckr
glucokinase regulator
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GCKR mRNA
CTD
PMID:37690743
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
G
Gcm1
glial cells missing transcription factor 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GCM1 mRNA
CTD
PMID:37690743
NCBI chr 8:78,925,687...78,938,924
Ensembl chr 8:78,925,687...78,938,924
G
Gcnt4
glucosaminyl (N-acetyl) transferase 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GCNT4 mRNA
CTD
PMID:37690743
NCBI chr 2:28,253,325...28,283,082
Ensembl chr 2:28,252,860...28,283,082
G
Gdap1l1
ganglioside-induced differentiation-associated protein 1-like 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GDAP1L1 mRNA
CTD
PMID:37690743
NCBI chr 3:152,110,225...152,129,693
Ensembl chr 3:152,110,253...152,128,711
G
Gdf5
growth differentiation factor 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GDF5 mRNA
CTD
PMID:37690743
NCBI chr 3:144,454,316...144,458,508
Ensembl chr 3:144,454,338...144,458,612
G
Gdf6
growth differentiation factor 6
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GDF6 mRNA
CTD
PMID:37690743
NCBI chr 5:22,996,246...23,012,567
Ensembl chr 5:22,996,246...23,012,567
G
Gdnf
glial cell derived neurotrophic factor
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GDNF mRNA
CTD
PMID:37690743
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
G
Gfra2
GDNF family receptor alpha 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GFRA2 mRNA
CTD
PMID:37690743
NCBI chr15:45,941,841...46,033,715
Ensembl chr15:45,941,828...46,033,714
G
Gfy
golgi-associated, olfactory signaling regulator
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GFY mRNA
CTD
PMID:37690743
NCBI chr 1:95,661,621...95,665,300
Ensembl chr 1:95,661,773...95,665,893
G
Gipc3
GIPC PDZ domain containing family, member 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GIPC3 mRNA
CTD
PMID:37690743
NCBI chr 7:8,374,941...8,383,281
G
Gjb2
gap junction protein, beta 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GJB2 mRNA
CTD
PMID:37690743
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
G
Gjb3
gap junction protein, beta 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GJB3 mRNA
CTD
PMID:37690743
NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:139,649,195...139,654,980
G
Gjc2
gap junction protein, gamma 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GJC2 mRNA
CTD
PMID:37690743
NCBI chr10:43,962,642...43,971,358
Ensembl chr10:43,962,642...43,970,467
G
Gldn
gliomedin
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GLDN mRNA
CTD
PMID:37690743
NCBI chr 8:54,679,015...54,723,198
Ensembl chr 8:54,679,119...54,723,196
G
Gli1
GLI family zinc finger 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GLI1 mRNA
CTD
PMID:37690743
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Glp1r
glucagon-like peptide 1 receptor
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GLP1R mRNA
CTD
PMID:37690743
NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241
G
Gna14
G protein subunit alpha 14
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GNA14 mRNA
CTD
PMID:37690743
NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423
G
Gnrhr
gonadotropin releasing hormone receptor
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GNRHR mRNA
CTD
PMID:37690743
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
G
Gpat3
glycerol-3-phosphate acyltransferase 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GPAT3 mRNA
CTD
PMID:37690743
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
G
Gpc5
glypican 5
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GPC5 mRNA
CTD
PMID:37690743
NCBI chr15:92,207,275...93,644,054
Ensembl chr15:92,239,176...93,643,282
G
Gpr142
G protein-coupled receptor 142
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GPR142 mRNA
CTD
PMID:37690743
NCBI chr10:99,840,069...99,843,410
Ensembl chr10:99,840,069...99,843,410
G
Gpr153
G protein-coupled receptor 153
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GPR153 mRNA
CTD
PMID:37690743
NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971
G
Gpr39
G protein-coupled receptor 39
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GPR39 mRNA
CTD
PMID:37690743
NCBI chr13:37,115,258...37,327,312
Ensembl chr13:37,115,102...37,328,267
G
Gpr61
G protein-coupled receptor 61
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GPR61 mRNA
CTD
PMID:37690743
NCBI chr 2:195,781,931...195,789,798
Ensembl chr 2:195,782,752...195,789,621
G
Grap
GRB2-related adaptor protein
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GRAP mRNA
CTD
PMID:37690743
NCBI chr10:46,298,965...46,352,057
Ensembl chr10:46,332,909...46,352,056
G
Greb1
growth regulating estrogen receptor binding 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of GREB1 mRNA
CTD
PMID:35307500
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
G
Grik2
glutamate ionotropic receptor kainate type subunit 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GRIK2 mRNA
CTD
PMID:37690743
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
G
Grik3
glutamate ionotropic receptor kainate type subunit 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GRIK3 mRNA
CTD
PMID:37690743
NCBI chr 5:137,767,865...137,989,617
Ensembl chr 5:137,767,865...137,984,307
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GRIN2A mRNA
CTD
PMID:37690743
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Grm2
glutamate metabotropic receptor 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GRM2 mRNA
CTD
PMID:37690743
NCBI chr 8:107,280,099...107,293,159
Ensembl chr 8:107,280,099...107,293,146
G
Gstm5l
glutathione S-transferase, mu 5-like
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GSTM5 mRNA
CTD
PMID:37690743
NCBI chr 2:195,544,424...195,549,895
Ensembl chr 2:195,544,426...195,628,961
G
Guca1a
guanylate cyclase activator 1A
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of GUCA1A mRNA
CTD
PMID:37690743
NCBI chr 9:13,588,988...13,598,566
Ensembl chr 9:13,588,525...13,598,565
G
H2aj
H2A.J histone
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of H2AJ mRNA
CTD
PMID:37690743
NCBI chr 4:169,675,718...169,676,202
Ensembl chr 4:169,675,752...169,677,006
G
Hap1
huntingtin-associated protein 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HAP1 mRNA
CTD
PMID:37690743
NCBI chr10:85,277,890...85,286,126
Ensembl chr10:85,277,890...85,286,126
G
Havcr1
hepatitis A virus cellular receptor 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HAVCR1 mRNA
CTD
PMID:37690743
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hck
HCK proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HCK mRNA
CTD
PMID:37690743
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
G
Hcls1
hematopoietic cell specific Lyn substrate 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of HCLS1 mRNA
CTD
PMID:37690743
NCBI chr11:63,817,482...63,840,943
Ensembl chr11:63,817,476...63,841,014
G
Hecw1
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of HECW1 mRNA
CTD
PMID:37690743
NCBI chr17:50,671,239...51,084,536
Ensembl chr17:50,670,954...51,080,720
G
Hes3
hes family bHLH transcription factor 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HES3 mRNA
CTD
PMID:37690743
NCBI chr 5:162,793,611...162,799,578
Ensembl chr 5:162,794,367...162,796,261
G
Heyl
hes-related family bHLH transcription factor with YRPW motif-like
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HEYL mRNA
CTD
PMID:37690743
NCBI chr 5:135,508,160...135,525,152
Ensembl chr 5:135,508,160...135,525,152
G
Hhipl2
HHIP like 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of HHIPL2 mRNA
CTD
PMID:37690743
NCBI chr13:95,054,685...95,074,609
Ensembl chr13:95,054,694...95,074,608
G
Hist2h3c2
histone cluster 2 H3 family member C2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of H3C14 mRNA
CTD
PMID:37690743
NCBI chr 2:183,837,296...183,837,721
Ensembl chr 2:183,837,303...183,837,752
G
Hoatz
HOATZ cilia and flagella associated protein
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of HOATZ mRNA
CTD
PMID:37690743
NCBI chr 8:51,385,931...51,409,796
Ensembl chr 8:51,388,382...51,412,514
G
Hoxa10
homeobox A10
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HOXA10 protein
CTD
PMID:34101200
NCBI chr 4:81,331,591...81,340,878
Ensembl chr 4:81,331,591...81,340,919
G
Hpca
hippocalcin
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HPCA mRNA
CTD
PMID:37690743
NCBI chr 5:141,455,616...141,466,252
Ensembl chr 5:141,455,613...141,463,841
G
Hpcal4
hippocalcin-like 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HPCAL4 mRNA
CTD
PMID:37690743
NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416
G
Hrc
histidine rich calcium binding protein
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HRC mRNA
CTD
PMID:37690743
NCBI chr 1:95,813,262...95,816,987
Ensembl chr 1:95,813,253...95,816,984
G
Hrh3
histamine receptor H3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HRH3 mRNA
CTD
PMID:37690743
NCBI chr 3:167,191,551...167,196,642
Ensembl chr 3:167,191,558...167,196,642
G
Hs3st2
heparan sulfate-glucosamine 3-sulfotransferase 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of HS3ST2 mRNA
CTD
PMID:37690743
NCBI chr 1:175,956,161...176,077,400
Ensembl chr 1:175,956,157...176,077,399
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HSD11B2 mRNA
CTD
PMID:37690743
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
G
Hsd17b1
hydroxysteroid (17-beta) dehydrogenase 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HSD17B1 mRNA
CTD
PMID:37690743
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
G
Hsh2d
hematopoietic SH2 domain containing
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HSH2D mRNA
CTD
PMID:37690743
NCBI chr16:17,630,519...17,649,932
Ensembl chr16:17,635,322...17,647,991
G
Hspa12b
heat shock protein family A (Hsp70) member 12B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HSPA12B mRNA
CTD
PMID:37690743
NCBI chr 3:118,346,372...118,364,374
Ensembl chr 3:118,346,354...118,364,737
G
Htr1d
5-hydroxytryptamine receptor 1D
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HTR1D mRNA
CTD
PMID:37690743
NCBI chr 5:148,656,252...148,676,532
Ensembl chr 5:148,674,495...148,675,619
G
Htr6
5-hydroxytryptamine receptor 6
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HTR6 mRNA
CTD
PMID:37690743
NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912
G
Icam5
intercellular adhesion molecule 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ICAM5 mRNA
CTD
PMID:37690743
NCBI chr 8:19,567,390...19,575,588
Ensembl chr 8:19,568,600...19,575,588
G
Ifi27l2a
interferon, alpha-inducible protein 27 like 2A
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of IFI27L2 mRNA
CTD
PMID:37690743
NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360
G
Igf2
insulin-like growth factor 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of IGF2 mRNA
CTD
PMID:37690743
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Il17re
interleukin 17 receptor E
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of IL17RE mRNA
CTD
PMID:37690743
NCBI chr 4:146,604,547...146,618,206
Ensembl chr 4:146,605,526...146,618,206
G
Il36rn
interleukin 36 receptor antagonist
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of IL36RN mRNA
CTD
PMID:37690743
NCBI chr 3:7,044,419...7,051,016
Ensembl chr 3:7,044,406...7,051,016
G
Ip6k3
inositol hexakisphosphate kinase 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of IP6K3 mRNA
CTD
PMID:37690743
NCBI chr20:5,223,863...5,245,443
Ensembl chr20:5,224,120...5,245,428
G
Iqank1
IQ motif and ankyrin repeat containing 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of IQANK1 mRNA
CTD
PMID:37690743
NCBI chr 7:107,724,962...107,759,163
Ensembl chr 7:107,724,997...107,759,162
G
Iqsec3
IQ motif and Sec7 domain ArfGEF 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of IQSEC3 mRNA
CTD
PMID:37690743
NCBI chr 4:154,610,933...154,707,310
Ensembl chr 4:154,610,934...154,707,310
G
Irf4
interferon regulatory factor 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of IRF4 mRNA
CTD
PMID:37690743
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
G
Irx1
iroquois homeobox 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of IRX1 mRNA
CTD
PMID:37690743
NCBI chr 1:31,294,615...31,300,444
Ensembl chr 1:31,294,615...31,300,444
G
Itga3
integrin subunit alpha 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ITGA3 mRNA
CTD
PMID:37690743
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
G
Itgb4
integrin subunit beta 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ITGB4 mRNA
CTD
PMID:37690743
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
G
Jak1
Janus kinase 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of JAK1 mRNA
CTD
PMID:37690743
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
G
Jakmip1
janus kinase and microtubule interacting protein 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of JAKMIP1 mRNA
CTD
PMID:37690743
NCBI chr14:73,646,299...73,766,830
Ensembl chr14:73,632,428...73,713,993
G
Jam2
junctional adhesion molecule 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of JAM2 mRNA
CTD
PMID:37690743
NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063
G
Jph4
junctophilin 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of JPH4 mRNA
CTD
PMID:37690743
NCBI chr15:28,579,579...28,588,903
Ensembl chr15:28,571,568...28,587,573
G
Kash5
KASH domain containing 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of KASH5 mRNA
CTD
PMID:37690743
NCBI chr 1:95,668,918...95,691,353
Ensembl chr 1:95,668,886...95,691,368
G
Kcnab3
potassium voltage-gated channel subfamily A regulatory beta subunit 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of KCNAB3 mRNA
CTD
PMID:37690743
NCBI chr10:54,047,830...54,056,401
Ensembl chr10:54,047,825...54,054,174
G
Kcnc1
potassium voltage-gated channel subfamily C member 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of KCNC1 mRNA
CTD
PMID:37690743
NCBI chr 1:96,902,953...96,944,744
Ensembl chr 1:96,902,953...96,944,744
G
Kcnf1
potassium voltage-gated channel modifier subfamily F member 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of KCNF1 mRNA
CTD
PMID:37690743
NCBI chr 6:39,962,301...39,964,979
Ensembl chr 6:39,962,307...39,964,979
G
Kcnh1
potassium voltage-gated channel subfamily H member 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of KCNH1 mRNA
CTD
PMID:37690743
NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740
G
Kcnh6
potassium voltage-gated channel subfamily H member 6
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of KCNH6 mRNA
CTD
PMID:37690743
NCBI chr10:90,949,240...90,970,746
Ensembl chr10:90,949,846...90,970,701
G
Kcnip1
potassium voltage-gated channel interacting protein 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of KCNIP1 mRNA
CTD
PMID:37690743
NCBI chr10:18,219,519...18,588,833
Ensembl chr10:18,219,519...18,589,045
G
Kcnip4
potassium voltage-gated channel interacting protein 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of KCNIP4 mRNA
CTD
PMID:37690743
NCBI chr14:61,380,699...62,531,399
Ensembl chr14:61,381,076...62,530,144
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of KCNJ11 mRNA
CTD
PMID:37690743
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
G
Kcnk9
potassium two pore domain channel subfamily K member 9
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of KCNK9 mRNA
CTD
PMID:37690743
NCBI chr 7:104,429,186...104,473,924
Ensembl chr 7:104,437,934...104,473,175
G
Kcnq3
potassium voltage-gated channel subfamily Q member 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of KCNQ3 mRNA
CTD
PMID:37690743
NCBI chr 7:97,730,219...98,025,652
Ensembl chr 7:97,730,465...98,025,653
G
Kiaa1614
KIAA1614 homolog
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of KIAA1614 mRNA
CTD
PMID:37690743
NCBI chr13:67,388,916...67,427,392
Ensembl chr13:67,389,044...67,421,272
G
Kif17
kinesin family member 17
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of KIF17 mRNA
CTD
PMID:37690743
NCBI chr 5:150,482,288...150,521,471
Ensembl chr 5:150,481,578...150,519,638
G
Kifc3
kinesin family member C3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of KIFC3 mRNA
CTD
PMID:37690743
NCBI chr19:9,825,114...9,920,371
Ensembl chr19:9,886,693...9,920,451
G
Kndc1
kinase non-catalytic C-lobe domain containing 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of KNDC1 mRNA
CTD
PMID:37690743
NCBI chr 1:194,689,962...194,738,353
Ensembl chr 1:194,690,135...194,738,362
G
Krt15
keratin 15
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of KRT15 mRNA
CTD
PMID:37690743
NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799
G
Krt80
keratin 80
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of KRT80 mRNA
CTD
PMID:37690743
NCBI chr 7:132,463,216...132,485,134
Ensembl chr 7:132,463,218...132,485,508
G
L3mbtl4
L3MBTL histone methyl-lysine binding protein 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of L3MBTL4 mRNA
CTD
PMID:37690743
NCBI chr 9:108,295,004...108,747,879
Ensembl chr 9:108,329,669...108,747,774
G
Lad1
ladinin 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LAD1 mRNA
CTD
PMID:37690743
NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967
G
Lag3
lymphocyte activating 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of LAG3 mRNA
CTD
PMID:37690743
NCBI chr 4:157,712,665...157,722,229
Ensembl chr 4:157,712,667...157,720,404
G
Lama4
laminin subunit alpha 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LAMA4 mRNA
CTD
PMID:37690743
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
G
Lamb3
laminin subunit beta 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LAMB3 mRNA
CTD
PMID:37690743
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
G
Lamc2
laminin subunit gamma 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LAMC2 mRNA
CTD
PMID:37690743
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
G
Ldhd
lactate dehydrogenase D
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of LDHD mRNA
CTD
PMID:37690743
NCBI chr19:39,583,529...39,588,397
Ensembl chr19:39,573,621...39,595,575
G
Lep
leptin
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of LEP mRNA
CTD
PMID:22956630
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lgals12
galectin 12
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LGALS12 mRNA
CTD
PMID:37690743
NCBI chr 1:204,832,065...204,842,759
Ensembl chr 1:204,832,065...204,842,759
G
Lgals5
galectin 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of LGALS16 mRNA
CTD
PMID:37690743
NCBI chr10:63,853,949...63,857,198
Ensembl chr10:63,853,935...63,857,153
G
Lingo3
leucine rich repeat and Ig domain containing 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of LINGO3 mRNA
CTD
PMID:37690743
NCBI chr 7:8,869,025...8,878,431
Ensembl chr 7:8,869,025...8,878,431
G
Lipg
lipase G, endothelial type
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LIPG mRNA
CTD
PMID:37690743
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
G
Lmx1b
LIM homeobox transcription factor 1 beta
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LMX1B mRNA
CTD
PMID:37690743
NCBI chr 3:16,862,195...16,940,899
Ensembl chr 3:16,862,195...16,940,899
G
Lox
lysyl oxidase
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LOX mRNA
CTD
PMID:37690743
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Loxl4
lysyl oxidase-like 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LOXL4 mRNA
CTD
PMID:37690743
NCBI chr 1:241,396,183...241,416,385
Ensembl chr 1:241,397,983...241,416,322
G
Lrfn1
leucine rich repeat and fibronectin type III domain containing 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of LRFN1 mRNA
CTD
PMID:37690743
NCBI chr 1:83,742,442...83,761,450
Ensembl chr 1:83,682,964...83,761,449
G
Lrfn2
leucine rich repeat and fibronectin type III domain containing 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of LRFN2 mRNA
CTD
PMID:37690743
NCBI chr 9:11,897,425...12,066,177
Ensembl chr 9:11,897,468...11,939,931
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LRG1 mRNA
CTD
PMID:37690743
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
G
Lrrc15
leucine rich repeat containing 15
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of LRRC15 mRNA
CTD
PMID:37690743
NCBI chr11:70,469,817...70,484,268
Ensembl chr11:70,469,804...70,484,267
G
Lrrc3
leucine rich repeat containing 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LRRC3 mRNA
CTD
PMID:37690743
NCBI chr20:10,758,919...10,763,736
Ensembl chr20:10,758,955...10,762,067
G
Lrrc4c
leucine rich repeat containing 4C
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of LRRC4C mRNA
CTD
PMID:37690743
NCBI chr 3:82,305,495...83,684,039
Ensembl chr 3:83,483,851...83,687,774
G
Lsmem2
leucine-rich single-pass membrane protein 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of LSMEM2 mRNA
CTD
PMID:37690743
NCBI chr 8:108,265,855...108,270,656
Ensembl chr 8:108,266,345...108,279,115
G
Ltb
lymphotoxin beta
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LTB mRNA
CTD
PMID:37690743
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
G
Lypd3
Ly6/Plaur domain containing 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of LYPD3 mRNA
CTD
PMID:37690743
NCBI chr 1:80,226,449...80,230,901
Ensembl chr 1:80,226,449...80,230,901
G
Mab21l4
mab-21 like 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MAB21L4 mRNA
CTD
PMID:37690743
NCBI chr 9:93,690,455...93,701,267
Ensembl chr 9:93,690,999...93,700,506
G
Mal
mal, T-cell differentiation protein
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MAL mRNA
CTD
PMID:37690743
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
G
Mamdc2
MAM domain containing 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MAMDC2 mRNA
CTD
PMID:37690743
NCBI chr 1:220,863,959...221,016,493
Ensembl chr 1:220,863,976...221,016,354
G
Maob
monoamine oxidase B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MAOB mRNA
CTD
PMID:37690743
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Mapt
microtubule-associated protein tau
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MAPT mRNA
CTD
PMID:37690743
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Marchf10
membrane associated ring-CH-type finger 10
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MARCHF10 mRNA
CTD
PMID:37690743
NCBI chr10:90,332,783...90,423,109
Ensembl chr10:90,332,784...90,421,588
G
Mat1a
methionine adenosyltransferase 1A
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MAT1A mRNA
CTD
PMID:37690743
NCBI chr16:16,983,084...17,001,284
Ensembl chr16:16,983,022...17,001,274
G
Matk
megakaryocyte-associated tyrosine kinase
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MATK mRNA
CTD
PMID:37690743
NCBI chr 7:8,456,990...8,465,947
Ensembl chr 7:8,456,998...8,462,022
G
Mboat7
membrane bound O-acyltransferase domain containing 7
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MBOAT7 mRNA
CTD
PMID:37690743
NCBI chr 1:65,525,206...65,539,538
Ensembl chr 1:65,525,213...65,539,538
G
Mctp1
multiple C2 and transmembrane domain containing 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MCTP1 mRNA
CTD
PMID:37690743
NCBI chr 2:6,071,408...6,761,833
Ensembl chr 2:6,065,808...6,761,833
G
Mef2b
myocyte enhancer factor 2B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MEF2B mRNA
CTD
PMID:37690743
NCBI chr16:19,253,008...19,269,514
Ensembl chr16:19,253,010...19,268,967
G
Megf11
multiple EGF-like-domains 11
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MEGF11 mRNA
CTD
PMID:37690743
NCBI chr 8:64,892,312...65,218,984
Ensembl chr 8:64,892,387...65,216,061
G
Meiob
meiosis specific with OB-fold
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MEIOB mRNA
CTD
PMID:37690743
NCBI chr10:13,833,170...13,865,684
Ensembl chr10:13,833,750...13,865,046
G
Mettl27
methyltransferase like 27
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of METTL27 mRNA
CTD
PMID:37690743
NCBI chr12:21,757,545...21,766,698
Ensembl chr12:21,757,329...21,766,685
G
Mfsd6l
major facilitator superfamily domain containing 6-like
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MFSD6L mRNA
CTD
PMID:37690743
NCBI chr10:53,258,794...53,260,887
Ensembl chr10:53,258,794...53,260,887
G
Mgst2
microsomal glutathione S-transferase 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MGST2 mRNA
CTD
PMID:37690743
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
G
Mid2
midline 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MID2 mRNA
CTD
PMID:37690743
NCBI chr X:104,354,692...104,456,757
Ensembl chr X:104,355,316...104,453,473
G
Mideas
mitotic deacetylase associated SANT domain protein
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MIDEAS mRNA
CTD
PMID:37690743
NCBI chr 6:103,784,779...103,854,470
Ensembl chr 6:103,787,873...103,829,178
G
Mip
major intrinsic protein of lens fiber
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MIP mRNA
CTD
PMID:37690743
NCBI chr 7:643,502...653,121
Ensembl chr 7:647,315...654,400
G
Mir375
microRNA 375
affects expression
ISO
ethyl-p-hydroxybenzoate affects the expression of MIR375
CTD
PMID:30481674
NCBI chr 9:76,457,911...76,457,985
Ensembl chr 9:76,457,911...76,457,985
G
Mmd2
monocyte to macrophage differentiation-associated 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MMD2 mRNA
CTD
PMID:37690743
NCBI chr12:11,962,733...12,009,776
Ensembl chr12:11,962,757...12,009,773
G
Mmp14
matrix metallopeptidase 14
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MMP14 mRNA
CTD
PMID:37690743
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
G
Mmp9
matrix metallopeptidase 9
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MMP9 protein
CTD
PMID:34101200
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Morn5
MORN repeat containing 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MORN5 mRNA
CTD
PMID:37690743
NCBI chr 3:19,402,221...19,430,075
Ensembl chr 3:19,401,801...19,430,083
G
Mpzl3
myelin protein zero-like 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MPZL3 mRNA
CTD
PMID:37690743
NCBI chr 8:45,360,475...45,380,662
Ensembl chr 8:45,349,054...45,380,662
G
Mrc1
mannose receptor, C type 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MRC1 mRNA
CTD
PMID:37690743
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
G
Mrgprb2
MAS-related GPR, member B2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MRGPRX1 mRNA
CTD
PMID:37690743
NCBI chr 1:98,401,140...98,403,162
Ensembl chr 1:98,401,538...98,415,284
G
Mtss2
MTSS I-BAR domain containing 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MTSS2 mRNA
CTD
PMID:37690743
NCBI chr19:38,692,793...38,714,575
Ensembl chr19:38,693,194...38,713,507
G
Muc2
mucin 2, oligomeric mucus/gel-forming
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MUC2 mRNA
CTD
PMID:37690743
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
Muc6
mucin 6, oligomeric mucus/gel-forming
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MUC6 mRNA
CTD
PMID:37690743
NCBI chr 1:196,726,678...196,764,842
Ensembl chr 1:196,726,807...196,764,842
G
Myadml2
myeloid-associated differentiation marker-like 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MYADML2 mRNA
CTD
PMID:37690743
NCBI chr10:105,922,557...105,927,867
Ensembl chr10:105,925,947...105,927,575
G
Mybpc3
myosin binding protein C3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MYBPC3 mRNA
CTD
PMID:37690743
NCBI chr 3:77,095,165...77,113,406
Ensembl chr 3:77,095,252...77,113,405
G
Mycbpap
Mycbp associated protein
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MYCBPAP mRNA
CTD
PMID:37690743
NCBI chr10:79,450,319...79,470,977
Ensembl chr10:79,450,324...79,470,828
G
Myh11
myosin heavy chain 11
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MYH11 mRNA
CTD
PMID:37690743
NCBI chr10:743,364...838,459
Ensembl chr10:743,685...838,459
G
Myh2
myosin heavy chain 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MYH2 mRNA
CTD
PMID:37690743
NCBI chr10:51,856,738...51,883,236
Ensembl chr10:51,856,738...51,883,236 Ensembl chr10:51,856,738...51,883,236
G
Myl7
myosin light chain 7
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MYL7 mRNA
CTD
PMID:37690743
NCBI chr14:80,780,684...80,783,259
Ensembl chr14:80,779,776...80,783,244
G
Myo15a
myosin XVA
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of MYO15A mRNA
CTD
PMID:37690743
NCBI chr10:45,277,619...45,335,953
Ensembl chr10:45,278,737...45,335,340
G
Myrfl
myelin regulatory factor-like
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MYRFL mRNA
CTD
PMID:37690743
NCBI chr 7:52,403,324...52,519,907
Ensembl chr 7:52,403,650...52,519,907
G
Myrip
myosin VIIA and Rab interacting protein
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of MYRIP mRNA
CTD
PMID:37690743
NCBI chr 8:120,017,749...120,184,821
Ensembl chr 8:120,017,524...120,183,833
G
Nacad
NAC alpha domain containing
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NACAD mRNA
CTD
PMID:37690743
NCBI chr14:81,465,299...81,473,866
Ensembl chr14:81,465,299...81,473,781
G
Nalf2
NALCN channel auxiliary factor 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NALF2 mRNA
CTD
PMID:37690743
NCBI chr X:64,925,100...64,951,074
Ensembl chr X:64,925,051...64,951,077
G
Nat8l
N-acetyltransferase 8-like
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NAT8L mRNA
CTD
PMID:37690743
NCBI chr14:76,756,077...76,762,712
Ensembl chr14:76,756,077...76,763,411
G
Ncam2
neural cell adhesion molecule 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of NCAM2 mRNA
CTD
PMID:37690743
NCBI chr11:20,104,974...20,592,168
Ensembl chr11:20,104,925...20,591,984
G
Nccrp1
NCCRP1, F-box associated domain containing
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of NCCRP1 mRNA
CTD
PMID:37690743
NCBI chr 1:83,835,083...83,838,620
Ensembl chr 1:83,835,083...83,838,676
G
Ncoa2
nuclear receptor coactivator 2
multiple interactions
ISO
ethyl-p-hydroxybenzoate inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]]
CTD
PMID:23583298
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
G
Ncr3
natural cytotoxicity triggering receptor 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NCR3 mRNA
CTD
PMID:37690743
NCBI chr20:3,637,242...3,643,748
Ensembl chr20:3,638,240...3,643,799
G
Ndrg1
N-myc downstream regulated 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of NDRG1 mRNA
CTD
PMID:37690743
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndufa3
NADH:ubiquinone oxidoreductase subunit A3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NDUFA3 mRNA
CTD
PMID:37690743
NCBI chr 1:65,597,567...65,600,197
Ensembl chr 1:65,597,578...65,600,235
G
Necab2
N-terminal EF-hand calcium binding protein 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NECAB2 mRNA
CTD
PMID:37690743
NCBI chr19:47,501,351...47,527,722
Ensembl chr19:47,501,302...47,527,684
G
Neurog2
neurogenin 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NEUROG2 mRNA
CTD
PMID:37690743
NCBI chr 2:216,092,709...216,095,276
Ensembl chr 2:216,093,363...216,094,154
G
Nfam1
NFAT activating protein with ITAM motif 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NFAM1 mRNA
CTD
PMID:37690743
NCBI chr 7:114,139,318...114,175,395
Ensembl chr 7:114,139,345...114,175,442
G
Ngf
nerve growth factor
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of NGF mRNA
CTD
PMID:37690743
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Niban1
niban apoptosis regulator 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of NIBAN1 mRNA
CTD
PMID:37690743
NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729
G
Nkain1
Sodium/potassium transporting ATPase interacting 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NKAIN1 mRNA
CTD
PMID:37690743
NCBI chr 5:142,747,702...142,792,665
Ensembl chr 5:142,747,505...142,791,863
G
Nkain3
Sodium/potassium transporting ATPase interacting 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NKAIN3 mRNA
CTD
PMID:37690743
NCBI chr 5:33,613,720...34,310,090
Ensembl chr 5:33,623,713...34,309,381
G
Nlgn3
neuroligin 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NLGN3 mRNA
CTD
PMID:37690743
NCBI chr X:66,427,926...66,457,378
Ensembl chr X:66,429,458...66,451,876
G
Nlrp10
NLR family, pyrin domain containing 10
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NLRP10 mRNA
CTD
PMID:37690743
NCBI chr 1:162,922,806...162,930,363
Ensembl chr 1:162,922,806...162,930,363
G
Nos1
nitric oxide synthase 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NOS1 mRNA
CTD
PMID:37690743
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nox3
NADPH oxidase 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of NOX3 mRNA
CTD
PMID:37690743
NCBI chr 1:44,238,012...44,302,851
Ensembl chr 1:44,236,992...44,302,851
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NPC1L1 mRNA
CTD
PMID:37690743
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
G
Npr3
natriuretic peptide receptor 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of NPR3 mRNA
CTD
PMID:37690743
NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
G
Nr0b1
nuclear receptor subfamily 0, group B, member 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of NR0B1 mRNA
CTD
PMID:37690743
NCBI chr X:50,756,886...50,761,014
Ensembl chr X:50,756,886...50,761,011
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases expression
ISO EXP
ethyl-p-hydroxybenzoate results in increased expression of NR1I2 mRNA
CTD
PMID:31472229
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr5a1
nuclear receptor subfamily 5, group A, member 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NR5A1 mRNA
CTD
PMID:37690743
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
G
Nrsn1
neurensin 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NRSN1 mRNA
CTD
PMID:37690743
NCBI chr17:39,806,238...39,824,550
Ensembl chr17:39,806,238...39,823,813
G
Nupr1
nuclear protein 1, transcriptional regulator
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of NUPR1 mRNA
CTD
PMID:37690743
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Olfm2
olfactomedin 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of OLFM2 mRNA
CTD
PMID:37690743
NCBI chr 8:19,204,472...19,282,154
Ensembl chr 8:19,204,475...19,282,117
G
Opn1sw
opsin 1, short wave sensitive
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of OPN1SW mRNA
CTD
PMID:37690743
NCBI chr 4:57,977,317...57,980,457
Ensembl chr 4:57,977,313...57,980,457
G
Oprd1
opioid receptor, delta 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of OPRD1 mRNA
CTD
PMID:37690743
NCBI chr 5:144,306,188...144,340,960
Ensembl chr 5:144,306,188...144,340,960
G
Optc
opticin
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of OPTC mRNA
CTD
PMID:37690743
NCBI chr13:45,353,954...45,368,254
Ensembl chr13:45,355,148...45,365,237
G
Or52n4c
olfactory receptor family 52 subfamily N member 4C
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of OR52N4 mRNA
CTD
PMID:37690743
NCBI chr 1:158,972,002...158,972,967
Ensembl chr 1:158,972,002...158,972,971
G
Orm1
orosomucoid 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ORM1 mRNA
CTD
PMID:37690743
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
G
Osmr
oncostatin M receptor
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of OSMR mRNA
CTD
PMID:37690743
NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262
G
Otoa
otoancorin
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of OTOA mRNA
CTD
PMID:37690743
NCBI chr 1:175,642,978...175,710,528
Ensembl chr 1:175,642,975...175,710,435
G
Otof
otoferlin
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of OTOF mRNA
CTD
PMID:37690743
NCBI chr 6:25,928,018...26,024,631
Ensembl chr 6:25,928,055...26,024,631
G
Ovca2
OVCA2 serine hydrolase domain containing
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of OVCA2 mRNA
CTD
PMID:37690743
NCBI chr10:60,026,048...60,029,211
Ensembl chr10:60,026,048...60,039,850
G
Ovch2
ovochymase 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of OVCH2 mRNA
CTD
PMID:37690743
NCBI chr 1:161,693,619...161,713,952
Ensembl chr 1:161,693,647...161,713,952
G
P2rx3
purinergic receptor P2X 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of P2RX3 mRNA
CTD
PMID:37690743
NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178
G
P2rx5
purinergic receptor P2X 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of P2RX5 mRNA
CTD
PMID:37690743
NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423
G
Pabpc1l2a
poly(A) binding protein, cytoplasmic 1-like 2A
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PABPC1L2A mRNA
CTD
PMID:37690743
NCBI chr X:68,023,845...68,026,508
G
Pabpc1l2b
poly(A) binding protein cytoplasmic 1 like 2B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PABPC1L2B mRNA
CTD
PMID:37690743
G
Pak5
p21 (RAC1) activated kinase 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PAK5 mRNA
CTD
PMID:37690743
NCBI chr 3:123,395,678...123,703,967
Ensembl chr 3:123,396,497...123,703,930
G
Pakap
paralemmin A kinase anchor protein
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PALM2AKAP2 mRNA
CTD
PMID:37690743
NCBI chr 5:72,536,986...72,648,524 NCBI chr 5:72,313,646...72,450,645
Ensembl chr 5:72,181,718...72,648,524
G
Pax8
paired box 8
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PAX8 mRNA
CTD
PMID:37690743
NCBI chr 3:7,185,721...7,242,363
Ensembl chr 3:7,185,723...7,242,363
G
Pcdha12
protocadherin alpha 12
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PCDHA12 mRNA
CTD
PMID:37690743
Ensembl chr18:28,581,225...28,846,211
G
Pcdhac1
protocadherin alpha subfamily C, 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PCDHAC1 mRNA
CTD
PMID:37690743
NCBI chr18:28,740,353...28,750,216
Ensembl chr18:28,581,225...28,846,211
G
Pcdhac2
protocadherin alpha subfamily C, 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PCDHAC2 mRNA
CTD
PMID:37690743
Ensembl chr18:28,581,225...28,846,211
G
Pcdhb15
protocadherin beta 15
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PCDHB7 mRNA
CTD
PMID:37690743
NCBI chr18:29,178,869...29,183,847
Ensembl chr18:29,181,052...29,183,804
G
Pcdhgc3
protocadherin gamma subfamily C, 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PCDHGC3 mRNA
CTD
PMID:37690743
NCBI chr18:29,633,016...29,667,865
Ensembl chr18:29,493,954...29,667,868
G
Pcdhgc5
protocadherin gamma subfamily C, 5
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PCDHGC5 mRNA
CTD
PMID:37690743
NCBI chr18:29,647,201...29,666,336
Ensembl chr18:29,493,954...29,667,868
G
Pde1b
phosphodiesterase 1B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PDE1B mRNA
CTD
PMID:37690743
NCBI chr 7:134,627,378...134,654,581
Ensembl chr 7:134,627,322...134,654,580
G
Pde7b
phosphodiesterase 7B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PDE7B mRNA
CTD
PMID:37690743
NCBI chr 1:15,174,001...15,493,267
Ensembl chr 1:15,182,704...15,492,900
G
Pdgfb
platelet derived growth factor subunit B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PDGFB mRNA
CTD
PMID:37690743
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdzrn4
PDZ domain containing RING finger 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PDZRN4 mRNA
CTD
PMID:37690743
NCBI chr 7:123,816,961...123,965,491
Ensembl chr 7:123,816,961...123,965,491
G
Pgm5
phosphoglucomutase 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PGM5 mRNA
CTD
PMID:37690743
NCBI chr 1:222,325,638...222,513,434
Ensembl chr 1:222,325,643...222,513,437
G
Pgr
progesterone receptor
increases expression decreases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PGR mRNA ethyl-p-hydroxybenzoate results in decreased expression of PGR mRNA
CTD
PMID:34101200 PMID:35307500
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Phactr3
phosphatase and actin regulator 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PHACTR3 mRNA
CTD
PMID:37690743
NCBI chr 3:165,205,247...165,423,692
Ensembl chr 3:165,205,255...165,423,153
G
Phyhd1
phytanoyl-CoA dioxygenase domain containing 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PHYHD1 mRNA
CTD
PMID:37690743
NCBI chr 3:13,535,670...13,553,797
Ensembl chr 3:13,540,056...13,553,797
G
Phyhip
phytanoyl-CoA 2-hydroxylase interacting protein
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PHYHIP mRNA
CTD
PMID:37690743
NCBI chr15:45,533,974...45,545,223
Ensembl chr15:45,533,974...45,545,221
G
Pianp
PILR alpha associated neural protein
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PIANP mRNA
CTD
PMID:37690743
NCBI chr 4:157,796,425...157,804,842
Ensembl chr 4:157,798,808...157,804,842
G
Pkp1
plakophilin 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PKP1 mRNA
CTD
PMID:37690743
NCBI chr13:47,309,607...47,357,432
Ensembl chr13:47,309,614...47,357,465
G
Pla2g4f
phospholipase A2, group IVF
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PLA2G4F mRNA
CTD
PMID:37690743
NCBI chr 3:107,249,053...107,266,201
Ensembl chr 3:107,250,075...107,264,689
G
Plch2
phospholipase C, eta 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PLCH2 mRNA
CTD
PMID:37690743
NCBI chr 5:165,544,209...165,613,769
Ensembl chr 5:165,544,200...165,602,356
G
Plek2
pleckstrin 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PLEK2 mRNA
CTD
PMID:37690743
NCBI chr 6:97,700,123...97,719,417
Ensembl chr 6:97,701,106...97,719,326
G
Plekhn1
pleckstrin homology domain containing N1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PLEKHN1 mRNA
CTD
PMID:37690743
NCBI chr 5:166,805,309...166,813,339
Ensembl chr 5:166,804,837...166,813,155
G
Plin4
perilipin 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PLIN4 mRNA
CTD
PMID:37690743
NCBI chr 9:929,168...938,062
Ensembl chr 9:929,176...938,056
G
Pnma3
PNMA family member 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PNMA3 mRNA
CTD
PMID:37690743
NCBI chr X:150,906,080...150,912,674
Ensembl chr X:150,906,278...150,910,839
G
Pnp
purine nucleoside phosphorylase
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PNP mRNA
CTD
PMID:37690743
NCBI chr15:24,170,607...24,178,269
Ensembl chr15:24,170,602...24,203,986
G
Podn
podocan
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PODN mRNA
CTD
PMID:37690743
NCBI chr 5:122,774,536...122,796,755
Ensembl chr 5:122,776,549...122,881,287
G
Podnl1
podocan-like 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PODNL1 mRNA
CTD
PMID:37690743
NCBI chr19:24,027,261...24,033,867
Ensembl chr19:24,027,297...24,033,846
G
Pon3
paraoxonase 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PON3 mRNA
CTD
PMID:37690743
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PPARG mRNA
CTD
PMID:22956630
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppef1
protein phosphatase with EF-hand domain 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PPEF1 mRNA
CTD
PMID:37690743
NCBI chr X:33,994,503...34,151,704
Ensembl chr X:34,021,350...34,151,701
G
Ppp3cc
protein phosphatase 3 catalytic subunit gamma
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PPP3CC mRNA
CTD
PMID:37690743
NCBI chr15:45,289,917...45,362,012
Ensembl chr15:45,290,373...45,361,832
G
Pram1
PML-RARA regulated adaptor molecule 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PRAM1 mRNA
CTD
PMID:37690743
NCBI chr 7:14,428,548...14,438,081
Ensembl chr 7:14,420,165...14,438,166
G
Prelp
proline and arginine rich end leucine rich repeat protein
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PRELP mRNA
CTD
PMID:37690743
NCBI chr13:45,368,407...45,391,480
Ensembl chr13:45,370,533...45,380,270
G
Prkcg
protein kinase C, gamma
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PRKCG mRNA
CTD
PMID:37690743
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384
G
Prmt8
protein arginine methyltransferase 8
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PRMT8 mRNA
CTD
PMID:37690743
NCBI chr 4:160,535,813...160,618,193
Ensembl chr 4:160,535,813...160,617,930
G
Proca1
protein interacting with cyclin A1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PROCA1 mRNA
CTD
PMID:37690743
NCBI chr10:63,090,018...63,102,941
Ensembl chr10:63,090,018...63,102,940
G
Prr9
proline rich 9
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PRR9 mRNA
CTD
PMID:37690743
NCBI chr 2:177,599,483...177,600,849
Ensembl chr 2:177,599,483...177,600,849
G
Prrt1
proline-rich transmembrane protein 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PRRT1 mRNA
CTD
PMID:37690743
NCBI chr20:4,117,957...4,121,643
Ensembl chr20:4,117,957...4,121,600
G
Prrt4
proline-rich transmembrane protein 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PRRT4 mRNA
CTD
PMID:37690743
NCBI chr 4:57,766,054...57,777,087
Ensembl chr 4:57,766,263...57,777,020
G
Prrx1
paired related homeobox 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PRRX1 mRNA
CTD
PMID:37690743
NCBI chr13:75,600,777...75,671,896
Ensembl chr13:75,601,706...75,670,866
G
Prss22
serine protease 22
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PRSS22 mRNA
CTD
PMID:37690743
NCBI chr10:13,029,153...13,033,863
Ensembl chr10:13,029,153...13,033,863
G
Prss33
serine protease 33
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PRSS33 mRNA
CTD
PMID:37690743
NCBI chr10:12,858,941...12,861,281
Ensembl chr10:12,858,941...12,861,281
G
Psapl1
prosaposin-like 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PSAPL1 mRNA
CTD
PMID:37690743
NCBI chr14:74,544,646...74,547,206
Ensembl chr14:74,544,646...74,547,206
G
Psca
prostate stem cell antigen
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PSCA mRNA
CTD
PMID:37690743
NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746
G
Psd2
pleckstrin and Sec7 domain containing 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PSD2 mRNA
CTD
PMID:37690743
NCBI chr18:27,564,912...27,616,674
Ensembl chr18:27,565,587...27,616,672
G
Psd4
pleckstrin and Sec7 domain containing 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PSD4 mRNA
CTD
PMID:37690743
NCBI chr 3:7,137,069...7,173,571
Ensembl chr 3:7,137,155...7,173,571
G
Pstpip1
proline-serine-threonine phosphatase-interacting protein 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PSTPIP1 mRNA
CTD
PMID:37690743
NCBI chr 8:56,499,287...56,538,593
Ensembl chr 8:56,499,590...56,538,580
G
Ptprm
protein tyrosine phosphatase, receptor type, M
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PTPRM mRNA
CTD
PMID:37690743
NCBI chr 9:106,639,573...107,343,698
Ensembl chr 9:106,639,573...107,343,698
G
Ptprn2
protein tyrosine phosphatase, receptor type N2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of PTPRN2 mRNA
CTD
PMID:37690743
NCBI chr 6:137,439,572...138,191,575
Ensembl chr 6:137,439,540...138,191,575
G
Pwwp2b
PWWP domain containing 2B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PWWP2B mRNA
CTD
PMID:37690743
NCBI chr 1:194,040,395...194,059,979
Ensembl chr 1:194,041,341...194,059,958
G
Pxk
PX domain containing serine/threonine kinase
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of PXK mRNA
CTD
PMID:37690743
NCBI chr15:16,759,857...16,828,452
Ensembl chr15:16,759,862...16,828,444
G
Qrfpr
pyroglutamylated RFamide peptide receptor
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of QRFPR mRNA
CTD
PMID:37690743
NCBI chr 2:119,053,083...119,096,864
Ensembl chr 2:119,053,511...119,096,792
G
Ramp2
receptor activity modifying protein 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of RAMP2 mRNA
CTD
PMID:37690743
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
G
Rasd2
RASD family, member 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of RASD2 mRNA
CTD
PMID:37690743
NCBI chr19:13,594,291...13,605,016
Ensembl chr19:13,594,291...13,605,016
G
Rasgef1b
RasGEF domain family, member 1B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of RASGEF1B mRNA
CTD
PMID:37690743
NCBI chr14:9,859,512...10,380,044
Ensembl chr14:9,860,247...10,379,741
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of RASGRF1 mRNA
CTD
PMID:37690743
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
G
Rbbp8nl
RBBP8 N-terminal like
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of RBBP8NL mRNA
CTD
PMID:37690743
NCBI chr 3:167,364,048...167,378,993
Ensembl chr 3:167,364,048...167,379,092
G
Rhoj
ras homolog family member J
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of RHOJ mRNA
CTD
PMID:37690743
NCBI chr 6:94,035,307...94,117,642
Ensembl chr 6:94,035,483...94,118,275
G
Rims4
regulating synaptic membrane exocytosis 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of RIMS4 mRNA
CTD
PMID:37690743
NCBI chr 3:152,520,982...152,585,070
Ensembl chr 3:152,524,095...152,584,780
G
Ripor1
RHO family interacting cell polarization regulator 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of RIPOR1 mRNA
CTD
PMID:37690743
NCBI chr19:33,477,750...33,506,424
Ensembl chr19:33,477,793...33,506,420
G
Rlbp1
retinaldehyde binding protein 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of RLBP1 mRNA
CTD
PMID:37690743
NCBI chr 1:133,308,920...133,322,296
Ensembl chr 1:133,308,938...133,322,296
G
Rnf112
ring finger protein 112
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of RNF112 mRNA
CTD
PMID:37690743
NCBI chr10:46,121,146...46,126,691
Ensembl chr10:46,121,148...46,126,699
G
Rnf152
ring finger protein 152
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of RNF152 mRNA
CTD
PMID:37690743
NCBI chr13:21,324,039...21,403,405
Ensembl chr13:21,323,824...21,403,113
G
Rnf43
ring finger protein 43
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of RNF43 mRNA
CTD
PMID:37690743
NCBI chr10:72,461,508...72,537,301
Ensembl chr10:72,464,348...72,536,977
G
Robo2
roundabout guidance receptor 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ROBO2 mRNA
CTD
PMID:37690743
NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536
G
Rspo1
R-spondin 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of RSPO1 mRNA
CTD
PMID:37690743
NCBI chr 5:137,251,629...137,273,273
Ensembl chr 5:137,251,659...137,272,933
G
Rspo4
R-spondin 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of RSPO4 mRNA
CTD
PMID:37690743
NCBI chr 3:140,357,256...140,391,780
Ensembl chr 3:140,357,424...140,388,254
G
RT1-Db1
RT1 class II, locus Db1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of HLA-DRB1 mRNA
CTD
PMID:37690743
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
RT1-DMb
RT1 class II, locus DMb
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of HLA-DMB mRNA
CTD
PMID:37690743
NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
G
Rtbdn
retbindin
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of RTBDN mRNA
CTD
PMID:37690743
NCBI chr19:23,197,506...23,205,544
Ensembl chr19:23,197,506...23,204,438
G
Rtl1
retrotransposon-like 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of RTL1 mRNA
CTD
PMID:37690743
NCBI chr 6:128,543,904...128,549,384
Ensembl chr 6:128,543,939...128,549,182
G
Rtl5
retrotransposon Gag like 5
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of RTL5 mRNA
CTD
PMID:37690743
NCBI chr X:67,183,948...67,188,747
Ensembl chr X:67,184,154...67,188,809
G
Rufy4
RUN and FYVE domain containing 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of RUFY4 mRNA
CTD
PMID:37690743
NCBI chr 9:75,702,937...75,727,719
Ensembl chr 9:75,703,750...75,723,525
G
S100a3
S100 calcium binding protein A3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of S100A3 mRNA
CTD
PMID:37690743
NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702
G
S100a4
S100 calcium-binding protein A4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of S100A4 mRNA
CTD
PMID:37690743
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
S100a9
S100 calcium binding protein A9
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of S100A9 mRNA
CTD
PMID:37690743
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Samd13
sterile alpha motif domain containing 13
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SAMD13 mRNA
CTD
PMID:37690743
NCBI chr 2:235,534,699...235,540,527
Ensembl chr 2:235,534,702...235,567,615
G
Sardh
sarcosine dehydrogenase
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SARDH mRNA
CTD
PMID:37690743
NCBI chr 3:10,510,553...10,575,342
Ensembl chr 3:10,510,553...10,573,874
G
Sbk2
SH3 domain binding kinase family, member 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SBK2 mRNA
CTD
PMID:37690743
NCBI chr 1:68,874,081...68,881,918
Ensembl chr 1:68,874,152...68,881,916
G
Sbk3
SH3 domain binding kinase family, member 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SBK3 mRNA
CTD
PMID:37690743
NCBI chr 1:68,867,847...68,873,249
Ensembl chr 1:68,868,238...68,871,392
G
Scel
sciellin
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SCEL mRNA
CTD
PMID:37690743
NCBI chr15:80,339,661...80,456,546
Ensembl chr15:80,339,951...80,456,372
G
Scn11a
sodium voltage-gated channel alpha subunit 11
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SCN11A mRNA
CTD
PMID:37690743
NCBI chr 8:119,495,550...119,567,044
Ensembl chr 8:119,496,769...119,567,044
G
Scn4a
sodium voltage-gated channel alpha subunit 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SCN4A mRNA
CTD
PMID:37690743
NCBI chr10:91,246,936...91,296,670
Ensembl chr10:91,246,936...91,296,545
G
Sec14l4
SEC14-like lipid binding 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SEC14L4 mRNA
CTD
PMID:37690743
NCBI chr14:78,912,750...78,928,799
Ensembl chr14:78,912,750...78,956,099
G
Sec14l5
SEC14-like lipid binding 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SEC14L5 mRNA
CTD
PMID:37690743
NCBI chr10:10,394,963...10,436,076
Ensembl chr10:10,396,878...10,435,917
G
Serpina5
serpin family A member 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SERPINA5 mRNA
CTD
PMID:37690743
NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407
G
Serpine3
serpin family E member 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SERPINE3 mRNA
CTD
PMID:37690743
NCBI chr15:36,908,816...36,931,825
Ensembl chr15:36,907,131...36,933,150
G
Sertad4
SERTA domain containing 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SERTAD4 mRNA
CTD
PMID:37690743
NCBI chr13:104,360,307...104,371,064
Ensembl chr13:104,360,307...104,370,546
G
Sgca
sarcoglycan, alpha
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SGCA mRNA
CTD
PMID:37690743
NCBI chr10:79,904,698...79,922,808
Ensembl chr10:79,908,738...79,922,813
G
Sh2d3a
SH2 domain containing 3A
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SH2D3A mRNA
CTD
PMID:37690743
NCBI chr 9:2,148,803...2,158,150
G
Sh3rf3
SH3 domain containing ring finger 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SH3RF3 mRNA
CTD
PMID:37690743
NCBI chr20:26,765,278...27,099,261
Ensembl chr20:26,765,015...27,099,257
G
Shank1
SH3 and multiple ankyrin repeat domains 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SHANK1 mRNA
CTD
PMID:37690743
NCBI chr 1:94,807,879...94,857,356
Ensembl chr 1:94,808,276...94,855,824
G
Shb
SH2 domain containing adaptor protein B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SHB mRNA
CTD
PMID:37690743
NCBI chr 5:59,678,066...59,785,443
Ensembl chr 5:59,678,216...59,785,538
G
Shbg
sex hormone binding globulin
affects binding
ISO
ethyl-p-hydroxybenzoate binds to SHBG protein
CTD
PMID:25349334
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
G
Shfl
shiftless antiviral inhibitor of ribosomal frameshifting
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SHFL mRNA
CTD
PMID:37690743
NCBI chr 8:19,408,298...19,414,084
Ensembl chr 8:19,408,333...19,413,971
G
Shisa7
shisa family member 7
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SHISA7 mRNA
CTD
PMID:37690743
NCBI chr 1:68,993,900...69,012,943
Ensembl chr 1:68,994,025...69,012,943
G
Siglec5
sialic acid binding Ig-like lectin 5
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SIGLEC6 mRNA
CTD
PMID:37690743
NCBI chr 1:93,768,190...93,776,696
Ensembl chr 1:93,768,319...93,776,694
G
Sim2
SIM bHLH transcription factor 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SIM2 mRNA
CTD
PMID:37690743
NCBI chr11:33,414,218...33,453,663
Ensembl chr11:33,414,218...33,453,663
G
Sit1
signaling threshold regulating transmembrane adaptor 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SIT1 mRNA
CTD
PMID:37690743
NCBI chr 5:57,740,212...57,741,838
Ensembl chr 5:57,740,218...57,741,838
G
Slc13a4
solute carrier family 13 member 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SLC13A4 mRNA
CTD
PMID:37690743
NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857
G
Slc17a7
solute carrier family 17 member 7
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SLC17A7 mRNA
CTD
PMID:37690743
NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588
G
Slc1a4
solute carrier family 1 member 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SLC1A4 mRNA
CTD
PMID:37690743
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
G
Slc24a4
solute carrier family 24 member 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SLC24A4 mRNA
CTD
PMID:37690743
NCBI chr 6:121,279,590...121,419,811
Ensembl chr 6:121,280,031...121,414,949
G
Slc26a5
solute carrier family 26 member 5
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SLC26A5 mRNA
CTD
PMID:37690743
NCBI chr 4:13,210,260...13,249,289
Ensembl chr 4:13,210,260...13,249,289
G
Slc30a3
solute carrier family 30 member 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SLC30A3 mRNA
CTD
PMID:37690743
NCBI chr 6:25,264,310...25,284,720
Ensembl chr 6:25,275,528...25,284,720
G
Slc34a2
solute carrier family 34 member 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SLC34A2 mRNA
CTD
PMID:37690743
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
G
Slc39a2
solute carrier family 39 member 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SLC39A2 mRNA
CTD
PMID:37690743
NCBI chr15:24,590,738...24,592,850
Ensembl chr15:24,590,738...24,592,850
G
Slc45a3
solute carrier family 45, member 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SLC45A3 mRNA
CTD
PMID:37690743
NCBI chr13:43,407,293...43,427,588
Ensembl chr13:43,407,293...43,427,588
G
Slc46a3
solute carrier family 46, member 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SLC46A3 mRNA
CTD
PMID:37690743
NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092
G
Slc5a5
solute carrier family 5 member 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SLC5A5 mRNA
CTD
PMID:37690743
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
G
Slc6a1
solute carrier family 6 member 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SLC6A1 mRNA
CTD
PMID:37690743
NCBI chr 4:147,448,961...147,482,295
Ensembl chr 4:147,466,965...147,482,293
G
Slc6a11
solute carrier family 6 member 11
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SLC6A11 mRNA
CTD
PMID:37690743
NCBI chr 4:147,297,972...147,413,319
Ensembl chr 4:147,297,969...147,413,443
G
Slc6a4
solute carrier family 6 member 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SLC6A4 mRNA
CTD
PMID:37690743
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Slc9a2
solute carrier family 9 member A2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SLC9A2 mRNA
CTD
PMID:37690743
NCBI chr 9:42,932,001...43,014,447
Ensembl chr 9:42,931,346...43,014,444
G
Slc9a5
solute carrier family 9 member A5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SLC9A5 mRNA
CTD
PMID:37690743
NCBI chr19:33,225,481...33,246,913
Ensembl chr19:33,226,816...33,246,903
G
Slco2a1
solute carrier organic anion transporter family, member 2a1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SLCO2A1 mRNA
CTD
PMID:37690743
NCBI chr 8:103,588,916...103,672,546
Ensembl chr 8:103,588,916...103,672,546
G
Slitrk3
SLIT and NTRK-like family, member 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SLITRK3 mRNA
CTD
PMID:37690743
NCBI chr 2:157,680,067...157,697,404
Ensembl chr 2:157,687,535...157,696,709
G
Smim11
small integral membrane protein 11
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SMIM11 mRNA
CTD
PMID:37690743
NCBI chr11:31,533,257...31,543,002
Ensembl chr11:31,532,764...31,543,002
G
Smim38
small integral membrane protein 38
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SMIM38 mRNA
CTD
PMID:37690743
NCBI chr 1:200,366,561...200,371,976
G
Smim5
small integral membrane protein 5
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SMIM5 mRNA
CTD
PMID:37690743
NCBI chr10:101,134,033...101,139,814
Ensembl chr10:101,134,033...101,139,813
G
Smpd1
sphingomyelin phosphodiesterase 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SMPD1 mRNA
CTD
PMID:37690743
NCBI chr 1:159,892,946...159,896,789
Ensembl chr 1:159,892,859...159,896,794
G
Sncb
synuclein, beta
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SNCB mRNA
CTD
PMID:37690743
NCBI chr17:9,846,802...9,855,013
Ensembl chr17:9,846,802...9,855,012
G
Sorcs3
sortilin-related VPS10 domain containing receptor 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SORCS3 mRNA
CTD
PMID:37690743
NCBI chr 1:247,099,178...247,734,027
Ensembl chr 1:247,099,408...247,734,027
G
Sowahb
sosondowah ankyrin repeat domain family member B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SOWAHB mRNA
CTD
PMID:37690743
NCBI chr14:15,029,203...15,033,038
Ensembl chr14:15,029,395...15,031,698
G
Sp140
SP140 nuclear body protein
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SP140 mRNA
CTD
PMID:37690743
NCBI chr 9:86,224,472...86,274,724
Ensembl chr 9:86,224,513...86,274,542
G
Spam1
sperm adhesion molecule 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SPAM1 mRNA
CTD
PMID:37690743
NCBI chr 4:53,302,745...53,312,913
Ensembl chr 4:53,302,745...53,312,908
G
Spmip8
sperm microtubule inner protein 8
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SPMIP8 mRNA
CTD
PMID:37690743
NCBI chr19:9,713,281...9,722,257
Ensembl chr19:9,712,641...9,722,257
G
Spock3
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SPOCK3 mRNA
CTD
PMID:37690743
NCBI chr16:26,382,895...26,815,943
Ensembl chr16:26,383,383...26,815,205
G
Sptb
spectrin, beta, erythrocytic
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SPTB mRNA
CTD
PMID:37690743
NCBI chr 6:95,310,342...95,437,221
Ensembl chr 6:95,310,326...95,437,118
G
Sptbn4
spectrin, beta, non-erythrocytic 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SPTBN4 mRNA
CTD
PMID:37690743
NCBI chr 1:82,650,750...82,738,345
Ensembl chr 1:82,650,751...82,737,228
G
Sptbn5
spectrin, beta, non-erythrocytic 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SPTBN5 mRNA
CTD
PMID:37690743
NCBI chr 3:107,013,783...107,054,878
Ensembl chr 3:107,013,265...107,054,324
G
Sptssb
serine palmitoyltransferase, small subunit B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SPTSSB mRNA
CTD
PMID:37690743
NCBI chr 2:154,133,728...154,162,127
Ensembl chr 2:154,133,733...154,163,120
G
Srpx2
sushi-repeat-containing protein, X-linked 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of SRPX2 mRNA
CTD
PMID:37690743
NCBI chr X:97,106,455...97,132,197
Ensembl chr X:97,106,561...97,132,195
G
Sstr3
somatostatin receptor 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SSTR3 mRNA
CTD
PMID:37690743
NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769
G
Stac2
SH3 and cysteine rich domain 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of STAC2 mRNA
CTD
PMID:37690743
NCBI chr10:83,032,418...83,048,260
Ensembl chr10:83,032,417...83,048,260
G
Stag3
STAG3 cohesin complex component
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of STAG3 mRNA
CTD
PMID:37690743
NCBI chr12:17,284,677...17,314,936
Ensembl chr12:17,284,794...17,314,935
G
Star
steroidogenic acute regulatory protein
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of STAR mRNA
CTD
PMID:37690743
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Steap3
STEAP3 metalloreductase
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of STEAP3 mRNA
CTD
PMID:37690743
NCBI chr13:31,351,954...31,397,344
Ensembl chr13:31,351,954...31,396,519
G
Strc
stereocilin
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of STRC mRNA
CTD
PMID:37690743
NCBI chr 3:108,335,920...108,355,114
Ensembl chr 3:108,335,747...108,354,134
G
Stx1b
syntaxin 1B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of STX1B mRNA
CTD
PMID:37690743
NCBI chr 1:182,415,544...182,434,385
Ensembl chr 1:182,415,546...182,441,280
G
Syce2
synaptonemal complex central element protein 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SYCE2 mRNA
CTD
PMID:37690743
NCBI chr19:23,266,236...23,291,265
Ensembl chr19:23,268,869...23,300,980
G
Syn1
synapsin I
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SYN1 mRNA
CTD
PMID:37690743
NCBI chr X:1,172,208...1,227,400
Ensembl chr X:1,172,208...1,227,396
G
Syt3
synaptotagmin 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SYT3 mRNA
CTD
PMID:37690743
NCBI chr 1:94,880,835...94,895,518
Ensembl chr 1:94,881,247...94,895,246
G
Syt5
synaptotagmin 5
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SYT5 mRNA
CTD
PMID:37690743
NCBI chr 1:69,277,351...69,285,071
Ensembl chr 1:69,277,351...69,285,067
G
Syt9
synaptotagmin 9
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of SYT9 mRNA
CTD
PMID:37690743
NCBI chr 1:161,275,882...161,456,384
Ensembl chr 1:161,275,734...161,455,007
G
Tacr1
tachykinin receptor 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TACR1 mRNA
CTD
PMID:37690743
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
G
Tbc1d2
TBC1 domain family, member 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TBC1D2 mRNA
CTD
PMID:37690743
NCBI chr 5:60,884,114...60,931,717
Ensembl chr 5:60,884,124...60,931,352
G
Tcte1
t-complex-associated testis expressed 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TCTE1 mRNA
CTD
PMID:37690743
NCBI chr 9:15,463,573...15,482,258
Ensembl chr 9:15,463,739...15,472,954
G
Tfap2b
transcription factor AP-2 beta
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TFAP2B mRNA
CTD
PMID:37690743
NCBI chr 9:21,786,251...21,816,054
Ensembl chr 9:21,786,258...21,814,520
G
Tff1
trefoil factor 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TFF1 mRNA
CTD
PMID:35307500
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TGFB1 mRNA
CTD
PMID:37690743
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TGFB1I1 mRNA
CTD
PMID:37690743
NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080
G
Tgfb3
transforming growth factor, beta 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TGFB3 mRNA
CTD
PMID:37690743
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Tgm2
transglutaminase 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TGM2 mRNA
CTD
PMID:37690743
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Thbd
thrombomodulin
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of THBD mRNA
CTD
PMID:37690743
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Thsd1
thrombospondin type 1 domain containing 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of THSD1 mRNA
CTD
PMID:37690743
NCBI chr16:69,771,408...69,804,844
Ensembl chr16:69,771,408...69,801,504
G
Tlcd3b
TLC domain containing 3B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TLCD3B mRNA
CTD
PMID:37690743
NCBI chr 1:181,421,104...181,439,744
Ensembl chr 1:181,422,830...181,439,743
G
Tle6
TLE family member 6, subcortical maternal complex member
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TLE6 mRNA
CTD
PMID:37690743
NCBI chr 7:8,107,050...8,118,639
Ensembl chr 7:8,107,207...8,118,639
G
Tle7
TLE family member 7
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TLE7 mRNA
CTD
PMID:37690743
NCBI chr19:38,072,682...38,084,942
Ensembl chr19:38,072,845...38,084,645
G
Tlr2
toll-like receptor 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TLR2 mRNA
CTD
PMID:37690743
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TLR4 mRNA
CTD
PMID:37690743
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr6
toll-like receptor 6
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TLR6 mRNA
CTD
PMID:37690743
NCBI chr14:43,362,164...43,374,500
Ensembl chr14:43,362,164...43,375,685
G
Tm4sf1
transmembrane 4 L six family member 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TM4SF1 mRNA
CTD
PMID:37690743
NCBI chr 2:141,456,950...141,466,146
Ensembl chr 2:141,453,310...141,466,146
G
Tmem114
transmembrane protein 114
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TMEM114 mRNA
CTD
PMID:37690743
NCBI chr10:7,168,998...7,185,251
Ensembl chr10:7,169,746...7,185,251
G
Tmem151b
transmembrane protein 151B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TMEM151B mRNA
CTD
PMID:37690743
NCBI chr 9:15,456,446...15,464,289
Ensembl chr 9:15,455,801...15,464,302
G
Tmem179
transmembrane protein 179
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TMEM179 mRNA
CTD
PMID:37690743
NCBI chr 6:131,569,289...131,580,413
Ensembl chr 6:131,569,290...131,580,305
G
Tmem184a
transmembrane protein 184A
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TMEM184A mRNA
CTD
PMID:37690743
NCBI chr12:14,817,508...14,833,109
Ensembl chr12:14,822,898...14,832,065
G
Tmem200b
transmembrane protein 200B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TMEM200B mRNA
CTD
PMID:37690743
NCBI chr 5:144,107,795...144,110,551
Ensembl chr 5:144,103,550...144,112,506
G
Tmem40
transmembrane protein 40
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TMEM40 mRNA
CTD
PMID:37690743
NCBI chr 4:148,791,509...148,819,287
Ensembl chr 4:148,791,505...148,823,665
G
Tmprss11f
transmembrane serine protease 11F
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TMPRSS11F mRNA
CTD
PMID:37690743
NCBI chr14:21,492,896...21,534,792
Ensembl chr14:21,429,418...21,534,809
G
Tmprss3
transmembrane serine protease 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TMPRSS3 mRNA
CTD
PMID:37690743
NCBI chr20:9,254,102...9,273,808
Ensembl chr20:9,254,109...9,274,363
G
Tnfrsf11b
TNF receptor superfamily member 11B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TNFRSF11B mRNA
CTD
PMID:37690743
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf1b
TNF receptor superfamily member 1B
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TNFRSF1B mRNA
CTD
PMID:37690743
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tnfrsf21
TNF receptor superfamily member 21
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TNFRSF21 mRNA
CTD
PMID:37690743
NCBI chr 9:17,879,156...17,954,085
Ensembl chr 9:17,879,156...17,954,085
G
Tnip3
TNFAIP3 interacting protein 3
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TNIP3 mRNA
CTD
PMID:37690743
NCBI chr 4:94,867,258...94,908,780
Ensembl chr 4:94,811,097...94,907,605
G
Tnn
tenascin N
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TNN mRNA
CTD
PMID:37690743
NCBI chr13:72,319,160...72,386,362
Ensembl chr13:72,319,155...72,408,156
G
Tns2
tensin 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TNS2 mRNA
CTD
PMID:37690743
NCBI chr 7:133,229,746...133,247,889
Ensembl chr 7:133,206,364...133,247,888
G
Tradd
TNFRSF1A-associated via death domain
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TRADD mRNA
CTD
PMID:37690743
NCBI chr19:33,136,148...33,142,714
Ensembl chr19:33,136,138...33,142,638
G
Treml2
triggering receptor expressed on myeloid cells-like 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TREML2 mRNA
CTD
PMID:37690743
NCBI chr 9:12,694,453...12,705,379
Ensembl chr 9:12,694,697...12,705,324
G
Trim69
tripartite motif-containing 69
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TRIM69 mRNA
CTD
PMID:37690743
NCBI chr 3:109,111,468...109,135,255
Ensembl chr 3:109,111,468...109,132,037
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TRPM2 mRNA
CTD
PMID:37690743
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
G
Trpv6
transient receptor potential cation channel, subfamily V, member 6
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TRPV6 mRNA
CTD
PMID:37690743
NCBI chr 4:70,507,347...70,523,013
Ensembl chr 4:70,507,348...70,523,017
G
Tsga10ip
testis specific 10 interacting protein
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TSGA10IP mRNA
CTD
PMID:37690743
NCBI chr 1:202,700,576...202,714,668
Ensembl chr 1:202,700,578...202,714,798
G
Tshz2
teashirt zinc finger homeobox 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TSHZ2 mRNA
CTD
PMID:37690743
NCBI chr 3:158,405,469...158,666,915
Ensembl chr 3:158,405,423...158,850,128
G
Tslp
thymic stromal lymphopoietin
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TSLP mRNA
CTD
PMID:37690743
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Tspear
thrombospondin-type laminin G domain and EAR repeats
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TSPEAR mRNA
CTD
PMID:37690743
NCBI chr20:10,771,806...10,837,419
Ensembl chr20:10,772,219...10,943,914
G
Ttbk1
tau tubulin kinase 1
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TTBK1 mRNA
CTD
PMID:37690743
NCBI chr 9:14,493,166...14,538,372
Ensembl chr 9:14,493,389...14,535,774
G
Ttll11
tubulin tyrosine ligase like11
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TTLL11 mRNA
CTD
PMID:37690743
NCBI chr 3:19,109,891...19,335,077
Ensembl chr 3:19,110,284...19,335,969
G
Ttll6
tubulin tyrosine ligase like 6
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TTLL6 mRNA
CTD
PMID:37690743
NCBI chr10:81,081,985...81,118,009
Ensembl chr10:81,091,975...81,127,234
G
Tubb3
tubulin, beta 3 class III
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of TUBB3 mRNA
CTD
PMID:37690743
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
G
Tubb4a
tubulin, beta 4A class IVa
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of TUBB4A mRNA
CTD
PMID:37690743
NCBI chr 9:1,917,841...1,925,286
Ensembl chr 9:1,917,845...1,925,291
G
Tyr
tyrosinase
affects response to substance
ISO
TYR protein affects the susceptibility to ethyl-p-hydroxybenzoate
CTD
PMID:19944085
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
G
Uap1l1
UDP-N-acetylglucosamine pyrophosphorylase 1 like 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of UAP1L1 mRNA
CTD
PMID:37690743
NCBI chr 3:8,172,335...8,180,505
Ensembl chr 3:8,173,216...8,180,443
G
Uba7
ubiquitin-like modifier activating enzyme 7
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of UBA7 mRNA
CTD
PMID:37690743
NCBI chr 8:108,665,289...108,674,097
Ensembl chr 8:108,665,292...108,674,099
G
Ucn2
urocortin 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of UCN2 mRNA
CTD
PMID:37690743
NCBI chr 8:109,637,624...109,639,173
Ensembl chr 8:109,638,285...109,639,172
G
Ucp1
uncoupling protein 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of UCP1 mRNA
CTD
PMID:37690743
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
G
Upk1a
uroplakin 1A
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of UPK1A mRNA
CTD
PMID:37690743
NCBI chr 1:85,859,672...85,870,147
Ensembl chr 1:85,859,671...85,870,354
G
Upk2
uroplakin 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of UPK2 mRNA
CTD
PMID:37690743
NCBI chr 8:44,779,198...44,781,190
Ensembl chr 8:44,779,198...44,781,190
G
Upk3bl1
uroplakin 3B like 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of UPK3BL1 mRNA
CTD
PMID:37690743
NCBI chr12:20,610,353...20,616,366
Ensembl chr12:20,610,353...20,616,366
G
Vax2
ventral anterior homeobox 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of VAX2 mRNA
CTD
PMID:37690743
NCBI chr 4:116,195,528...116,219,597
Ensembl chr 4:116,195,528...116,219,594
G
Vwa1
von Willebrand factor A domain containing 1
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of VWA1 mRNA
CTD
PMID:37690743
NCBI chr 5:166,377,451...166,382,784
Ensembl chr 5:166,377,455...166,382,637
G
Vwa5b2
von Willebrand factor A domain containing 5B2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of VWA5B2 mRNA
CTD
PMID:37690743
NCBI chr11:80,306,067...80,323,220
Ensembl chr11:80,306,350...80,323,220
G
Wnt2
Wnt family member 2
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of WNT2 mRNA
CTD
PMID:37690743
NCBI chr 4:46,328,408...46,374,673
Ensembl chr 4:46,333,998...46,374,402
G
Wnt3a
Wnt family member 3A
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of WNT3A mRNA
CTD
PMID:37690743
NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324
G
Wnt7a
Wnt family member 7A
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of WNT7A mRNA
CTD
PMID:37690743
NCBI chr 4:123,863,108...123,908,981
Ensembl chr 4:123,863,108...123,908,981
G
Wnt7b
Wnt family member 7B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of WNT7B mRNA
CTD
PMID:37690743
NCBI chr 7:116,634,817...116,679,459
Ensembl chr 7:116,634,814...116,679,581
G
Wnt9b
Wnt family member 9B
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of WNT9B mRNA
CTD
PMID:37690743
NCBI chr10:88,635,330...88,657,035
Ensembl chr10:88,635,331...88,657,035
G
Xpnpep2
X-prolyl aminopeptidase 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of XPNPEP2 mRNA
CTD
PMID:37690743
NCBI chr X:127,287,765...127,317,036
Ensembl chr X:127,287,979...127,317,223
G
Ybx2
Y box binding protein 2
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of YBX2 mRNA
CTD
PMID:37690743
NCBI chr10:54,659,719...54,665,371
Ensembl chr10:54,659,719...54,665,371
G
Zfp488
zinc finger protein 488
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ZNF488 mRNA
CTD
PMID:37690743
NCBI chr16:9,283,039...9,293,681
Ensembl chr16:9,283,043...9,293,671
G
Zfp536
zinc finger protein 536
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ZNF536 mRNA
CTD
PMID:37690743
NCBI chr 1:90,000,359...90,463,423
Ensembl chr 1:90,002,858...90,462,990
G
Zic4
Zic family member 4
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ZIC4 mRNA
CTD
PMID:37690743
NCBI chr 8:91,916,356...91,936,525
Ensembl chr 8:91,920,015...91,935,368
G
Zmynd15
zinc finger, MYND-type containing 15
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ZMYND15 mRNA
CTD
PMID:37690743
NCBI chr10:55,171,198...55,177,812
Ensembl chr10:55,171,198...55,177,812
G
Zp3
zona pellucida glycoprotein 3
decreases expression
ISO
ethyl-p-hydroxybenzoate results in decreased expression of ZP3 mRNA
CTD
PMID:37690743
NCBI chr12:20,690,547...20,697,513
Ensembl chr12:20,690,547...20,697,513
G
Zscan4f
zinc finger and SCAN domain containing 4F
increases expression
ISO
ethyl-p-hydroxybenzoate results in increased expression of ZSCAN4 mRNA
CTD
PMID:37690743
NCBI chr 7:13,759,115...13,762,279
Ensembl chr 7:13,759,115...13,762,279
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all